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Prostate cancer has been the most common non-skin cancer and the second leading cause 
of cancer-related death, affecting 1/6 American men. It is 35% more likely to be 
diagnosed with prostate cancer for a man than a woman is to be diagnosed with breast 
cancer 
[1]
. The estimated new cases and deaths in 2009 by National Cancer Institute in 
United States are: 218,890 (New cases) and 27,050 (Deaths) 
[2]
. Although only 1 in 
10,000 under age 40 will be diagnosed, the rate shoots up to 1 in 39 for ages 40 to 59, and 
1 in 14 for ages 60 to 69. In fact, more than 65% of all prostate cancers are diagnosed in 
men over the age of 65. The roles of race and family history are important as well. 
African American men are 61% more likely to develop prostate cancer compared with 
Caucasian men and are nearly 2.5 times as likely to die from the disease. Men with a 
single first-degree relative—father, brother or son—with a history of prostate cancer are 
twice as likely to develop the disease, while those with two or more relatives are nearly 
four times as likely to be diagnosed. The risk is even higher if the affected family 




1.1 Prostate cancer 
Human prostate (Fig. 1) is a gland in the male reproductive system. It surrounds 
the part of the urethra (the tube that empties the bladder) just below the bladder, and 
produces a fluid that forms part of the semen. The urethra runs directly through the 
prostate, the rectum, or the lower end of the bowel, sits just behind the prostate and the 
bladder. The seminal vesicles, two little glands that secrete about 60% of the substances 
that make up semen are above the prostate. What running alongside and attached to the 
sides of the prostate are the nerves that control erectile function. 
 
Figure 1 Human Prostate 
 
In 1988, McNeal divided prostate anatomically into several zones which were 
shown in Fig. 2 with sagittal view and coronal view 
[3]
. Those three zones include: 
Peripheral Zone (PZ) covering the dorsal, lateral and apical parts of the prostate; 
Transition Zone (TZ) consists of two lobes, located anteriorly between the proximal 
urethra and the lateral parts of the PZ; Central Zone (CZ) is cone-shaped with its base at 
the bladder neck and the tip at the verumontanum. Studies showed that about 68% of 
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Figure 2 Anatomic zones of prostate: 
PZ: peripheral zone; TZ: transition zone; CZ: central zone 
 
Prostate cancer is hard to evaluate because of its unusually wide range of 
biological potential between incidence and mortality. Some patients died quickly after 
diagnosis while others could live as long as normal life span. Current prediction of 
prognosis for prostate cancer by combined histological grading and clinical staging was 
introduced by Gleason et, al., in 1974. The four stages of prostate cancer are described in 
Fig. 3. Stage I (Localized): cancer found in the prostate only; Stage II (Localized): cancer 
is more advanced but has not spread outside the prostate; Stage III (Locally advanced): 
cancer which has spread beyond the outer layer of the prostate to nearby tissues; Stage IV 






Figure 3 Different stages of prostate cancer 
 
The Gleason grading system in Fig. 4 shows a five distinct patters of how prostate 
cancer cells awkward from normal tissue cells. Gleason 1 means that the tumor cells look 
almost the same as normal cells while Gleason 5 shows that the tumor cells look much 
different to normal cells. During the examination, pathologist assigns one Gleason grade 
to the most common pattern and a second Gleason grade to the next most common 






Figure 4 Gleason grading of prostate cancer 
[8]
. 
1.2 Prostate cancer screening 
Currently, prostate cancer early screening is performed by measurement of serum 
prostate-specific antigen (PSA), digital rectal examination (DRE) and a combination of 
these two tests. PSA is a protein produced by the prostate and released in very small 
amounts into the bloodstream. When there is a problem with the prostate, such as prostate 
cancer development and growth, more and more PSA is released, until it reaches a level 
where it can be easily detected in the blood. During a PSA test (Fig. 5a), a small amount 
of blood is drawn from the arm, and the level of PSA is measured. PSA levels less than 4 
ng/mL are usually considered "normal," levels over 10 ng/mL are usually considered 
"high," and results between 4 and 10 ng/mL are usually considered "intermediate." 
However, PSA can also be elevated if other prostate problems are present and some men 
with prostate cancer may have "low" levels of PSA. 
Another technique, DRE (Fig. 5b), is also used to detect the presence of disease as 
well. During a DRE exam, the experienced physician inserts a gloved, lubricated finger 
into the rectum and examines the prostate for any irregularities in size, shape, and texture. 
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Usually, the DRE can be used by urologists to help distinguish between prostate cancer 




 (a)                                                                          (b) 
Figure 5 Prostate screening PSA (a) and DRE (b) 
 
In prostate detection, the sensitivity is defined by: 
results negative false of   results positive  trueof 





   
                Equation 1 
while the specificity is defined by: 
results positive false of   results negative  trueof 





   
                Equation 2 
and the detection rate is an averaged value of sensitivity and specificity. 
Among those exams mentioned above, Prostate specific antigen (PSA) test turns 
on the alert of prostate cancer very early; however, because of the distribution of cancer 
and PSA in the population, the sensitivity and specificity of PSA for cancer detection for 
levels of 1.1, 2.6 and 4.0 mg/L are 83.4%/38.9%, 40.5%/81.1%, and 20.5%/93.8%, 
7 
 
respectively. The higher sensitivity of the PSA test will give lower specificity of the 
prostate cancer; while on the contrary, the higher specificity of the PSA level setting will 
lead to a lower sensitivity of the PSA test. The majority of the positive test results have 
been demonstrated as the false alarm between 60~70%. PSA test also has approximately 
15% of false negative reassurance rate. 
Digital rectal examination (DRE) augments PSA test when the nodule is palpable, 
but the sensitivity of DRE is low which mainly depends on the experience of physicians. 
Up to 20% of men with abnormal DRE results have prostate cancer; on the other hand, 
60% of men with prostate cancer have normal DRE results. Among those prostate 
cancers detected by DRE alone, 70% of them have already spread beyond the prostate 
gland. 
 




When there is a suspicion of prostate cancer, a biopsy must be taken to obtain the 
pathologic evidence as well to confirm neoplastic lesions and to determine their clinical 
significance for treatment planning. Currently, trans-rectal ultrasound (TRUS) guided 
prostate biopsy is the gold-standard of prostate cancer diagnostic. In TRUS-guided 
biopsy (Fig. 6), a biopsy needle loaded in a spring-action automatic biopsy device is 
commonly used to procure multiple prostate biopsy specimens. The tissue samples have 
to be taken throughout the prostate at minimum of 6 sites as a systematic yet random 
approach. The current standard of prostate biopsy routinely uses 10 to 12 cores of tissue 
obtained throughout the prostate for the initial assessment. Pathologists examined the 
biopsy samples under the microscope to tell if there are prostate cancer cells and how 
they grow. A cancer grade (Gleason Score) is to determine the degree how the tumor 
cells look different from normal cells. It should be noted that the majority of biopsies are 
found to be negative, and in men with persistent suspicion of prostate cancer after several 
negative biopsies, repeated biopsy and more extensive protocols (>12 cores) up to 
saturation biopsy (24 cores) represent a necessary diagnostic procedure 
[14][15]
. 
1.3 Prostate imaging techniques 
There are several imaging techniques that have been applied to prostate imaging. 
Among them: Ultrasonography, Magnetic Resonance Imaging (MRI), Computed 
Tomography (CT) and Positron Emission Tomography (PET) are the main imaging 
techniques in clinical applications or in the research 
[16]
. 
Ultrasonography is a technique in which high-frequency sound waves are 
bounced off internal organs, with the echo pattern converted into a two-dimensional 
image of the structures beneath the transducer. For prostate imaging, trans-rectal 
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ultrasonography is the most commonly used imaging technique to determine the prostate 
size, zonal anatomy and potential lesions because of its portability, low cost and 
capability to perform real-time imaging 
[17]
. 
MRI, formerly called nuclear magnetic resonance imaging (NMRI), uses a 
powerful magnetic field to align the nuclear magnetization of hydrogen atoms in water in 
the body. Radio frequency field is used to systematically alter the alignment of this 
magnetization, causing the hydrogen nuclei to produce a rotating magnetic field 
detectable by the scanner. MRI allows anatomical and functional assessment of the 
prostate which has better soft-tissue resolution than any other imaging method enabling 
more-accurate lesion detection and local staging 
[18]
. 
CT is a technique with ionizing radiation that uses multiple two-dimensional X-
ray images, taken around a single axis of rotation to generate a three-dimensional image 
of an object. Although it is a widely used modality in both diagnosis and follow-up of 
nearly all malignancies, it has limited role in the imaging of prostate cancer due to its 
poor soft-tissue contrast resolution. The major role of CT in prostate imaging is for the 
detection of bony involvement and in nodal staging 
[19]
. 
PET is a nuclear medicine imaging technique which produces a three-dimensional 
image of functional processes in the body. It detects pairs of gamma rays emitted by a 
positron-emitting radionuclide (tracer), which is introduced into the body on a 
biologically active molecule. Images of tracer concentration in 3-dimensional or 4-
dimensional space within the body are then reconstructed by computer analysis. PET has 
high sensitivity with only a small amount of radioactive compound. Its signal is 
10 
 




Considering the advantages of imaging speed and system expense, current 
standard prostate biopsy procedure is guided by trans-rectal ultrasound (TRUS) when 
indicated by elevated serum prostate-specific antigen (PSA) levels or abnormal digital 




Figure 7 TRUS image of prostate cancer 
However, TRUS has some unique limitations on the prostate cancer diagnosis. 
Fig. 7 is an axial trans-rectal ultrasound image of prostate. Although the resolution of the 
sono-graphic imaging of the prostate is high enough to define the prostate region from the 
capsule, the contrast of ultrasound imaging cannot reliably tell the lesion from the normal 
tissue. Statistically less than 60% of neoplastic lesions appear hypoechoic on TRUS 
while most of the remaining neoplastic lesions appear isoechoic. Therefore, most of the 
ultrasound guided biopsies performed following a ―systematic sampling‖ strategy. Some 
templates with 6~12 cores cover two lobes (prostate right lobe and left lobe) from cranial 
aspect to caudal aspect. Although some advanced techniques like Doppler-ultrasound 
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may detect the regions of hyper-vascularity, but most small tumors are not angiogenic 
that limits this technique in the prostate cancer diagnosis at early stage. The 
ultrasonographic finding of the classic hypoechoic peripheral zone lesion has a sensitivity 
of 85.5%, specificity of 28.4%, positive predictive value of 29%, negative predictive 
value of 85.2% and overall accuracy of 43% in prostate cancer detection. The prevalence 
of isoechoic or nearly invisible prostate cancers visualized with TRUS ranges from 25 to 
42%. As a result, the overall cancer detection rates for patients undergoing repeat prostate 
needle biopsy with various biopsy templates range from 10% - 38%
[23]~[28]
. 
Since there are no significant biologic differences noted between isoechoic and 
hypoechoic prostate cancers, TRUS does not reliably differentiate neoplastic from benign 
tumors. Improving the cancer detection rate using TRUS-guided biopsy requires TRUS 
imaging be augmented or aided with a potentially pathognomonic indicator of prostate 
cancer development that can be detected non-invasively 
[29][30]
. 
1.4 Near-infrared diffuse optical tomography 
Near-infrared (NIR) diffuse optical tomography (DOT) has been demonstrated as 
a non-invasive diagnostic imaging technique with high functional contrast between the 
malignant tissue and normal tissue since 1970s. This optical measurement has several 
centimeter imaging depth in tissue because the tissue is dominated by water which has 
low absorption in NIR region (600~1000nm). 
Recently near-infrared diffuse optical tomography approach has been widely used 
to detect breast cancer, by providing sufficient contrast between the normal breast tissue 
and the lesion 
[31]~[36]
. Some groups, including ours, have extended this method toward 
prostate imaging. It has been suggested that the accuracy of prostate biopsy may be 
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improved if the TRUS imaging could be augmented with a functional or ―surrogate‖ 
marker of a prostate tumor. Based on decades of research on cancer imaging and prostate 
measurements, near-infrared (NIR) tomography, being non-ionizing and minimally-
invasive similar to TRUS, has the potential of providing such functional or ―surrogate‖ 
markers. NIR optical tomography, if carried out trans-rectally, may improve the 




1.5 Thesis overview 
The objectives of this work are to develop an endo-rectal NIR imaging applicator 
coupled with TRUS in sagittal plane, to validate the performance of the trans-rectal NIR 
tomography with or without the incorporation from the TRUS prior, and to demonstrate 
the combined trans-rectal US/NIR system by in-vivo experiments with animal model. The 
successful outcome of this research will pave the way to increase the imaging contrast 
and help radiologists to locate the suspicious lesions in the prostate which will ultimately 
improve the biopsy accuracy. 
Chapter I is a brief introduction of the prostate cancer and commonly used 
prostate cancer imaging and diagnostic methods. In Chapter II, a review of the NIR 
diffuse optical tomography describes the optical imaging reconstruction algorithm in 
detail. Previous studies on the prostate optical measurement are also presented in Chapter 
II. Chapter III describes the design of the combined endo-rectal US/NIR imaging 
applicator and system. Chapter IV provides comprehensive experimental results to 
validate the combined imaging system. The in-vivo optical measurements on canine 
prostate with a tumor model are reported in Chapter V at single wavelength. Dual-band 
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optical imaging on canine prostate with tumor model to map the prostate total 







NEAR INFRARED DIFFUSE OPTICAL TOMOGRAPHY 
 
In near–infrared (NIR) diffuse optical tomography, illumination from several sources into 
a diffuse medium is observed by several detectors. A model for light propagation in a 
diffuse-dominant medium is applied to localize the optical properties of target. The first 
optical imaging of bio-tissue could be traced back to 1920s of the trans-illumination 
experiment through breast originally proposed by Cutler 
[40]
. With the derivation of 
theory and the development of the techniques, multiple wavelength optical measurements 
to quantify the oxygen and de-oxygen hemoglobin concentration was introduced in 1970s 
by Jobsis 
[41]
 which was considered as the most important demonstration of the potential 
NIR spectroscopic measurement for tissue volume. In recent NIR imaging studies on 
human subjects, the contrast of hemoglobin of cancerous tissue and normal tissue has 
been estimated within the range of 2:1 to 3:1. This chapter will introduce some basic 





When light propagates through the biological tissue, the attenuation of the light 
power was caused by optical absorption and optical scattering which can be obtained by 
diffuse optical tomography (DOT). 
2.1 Optical absorption 
Optical absorption in molecular transitions includes electronic transition and 
vibrational transition. Electronic transition allows electrons to move freely up and down 
the different energy levels (or quantum states). In vibrational transition, the nuclei of the 
atoms within a molecule vibrate resonantly with wavelengths in the infrared spectrum. 
For pure optical absorbing medium, the relation between the attenuation of light power I 
and the optical path-length l follows a relation which was discovered by Bouguer (1729) 








               Equation 3 
Where I is the light intensity after passing through the medium and I0 is the 




In 1852, Beer found that the compound optical absorption was related to the 
concentration C of those absorbing species in the medium which can be expressed as: 
          i
n
i




2211            Equation 4 















              Equation 5 
16 
 
Where εi is the extinction coefficient (mm
-1
/Mol) with respected to different 
wavelength λ and ci is the concentration of the species in the medium (Mol). 
2.2 Optical scattering 
Light scattering occurs when charged particles in a medium are set into oscillatory 
motion by the electric field of the incident wave and re-emit light of the same frequency 
as the primary wave. This re-radiation pattern is in the form of a dipole pattern. As the 
dipoles collapse and re-radiate their energy, the radiation patterns from all dipoles will 
interfere destructively in the off-axis directions and will constructively interfere in the 
forward and backward directions. The time delay in the process of dipole formation and 
re-radiation after dipole collapse causes a slower light speed than that in vacuum. The 
ratio of those two different speeds is presented by refractive index: 
mc
c
n 0                Equation 6 
Where c0 is the light speed in vacuum, and cm is the light speed in the medium. 
The scattering coefficient µs is defined as the probability of photon scattering in a 
medium per unit path length. For single scattering, it can be expressed as: 
sss                  Equation 7 
Where ρs is the concentration of the scattering objects and σs is the scattering 
cross-section which can be described as: 
AQss                 Equation 8 




Figure 8 Optical scattering 
 
Another parameter often used in biomedical optics is the reduced scattering 
coefficient: 
  ss g   1             Equation 9 
The ―anisotropy‖ g is the projection of the scattered angle θ onto the forward 
direction as the following equation: 




sin2coscos dpg          Equation 10 
For biological tissues, a typical value for g is in the range of 0.90~0.95 The 
probability density function p(θ) for isotopic scattering which is equal at all directions is 
4
1
. For a given value of g, a commonly used scattering function in biomedical optics is 


















           Equation 11 
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being scattered. And after traveling a ―reduced mean free path‖ (MFP’=
S
1
), it becomes 
isotropic scattering. 
In biological tissue, large objects like mitochondria, nuclei and collagen fiber 
bundles are usually comparable or larger than the wavelength of NIR light. The scattering 
pattern is dominated by Mie scattering which is wavelength dependant. Studies have 
found an empirical relation between the reduced scattering and different wavelength. 
b
s a
               Equation 12 
Where a is the scattering amplitude and b is the scattering power. The value of both 
scattering power and amplitude depend on the scatterer size and density. For large 
scatterers, b and a values are usually lower than small scatterers. When the scatterer size 
is much smaller than the wavelength, b is close to 4 as expected from Rayleigh scattering. 
Table 1 lists some measured scattering amplitude and power of different tissues from 
previous studies. 
Table 1 Fitted scattering amplitude and power of biological tissue 
Study Phantom (λ in µm) Amplitude Power 
Saidi et al, 1995 
[47]
 1% Intralipid 1.41 0.758 
Solonenko et al, 2002 
[48]
 Bowel (canine) 0.70 1.24 
Solonenko et al, 2002 
[48]
 Kidney (canine) 1.23 1.51 
Solonenko et al, 2002 
[48]
 Prostate (canine) 0.97 0.876 
Srinivasan et al, 2007 
[49]
 Breast (Human) 1.2±0.25 0.7±0.44 
Svensson et al, 2008 
[50]
 Prostate (human) 31 1.6 
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2.3 Diffusion approximation 
As the electromagnetic wave propagation described by Maxwell’s equations, the 
propagation of light in turbid media can be expressed by the radiative transport equation 
(RTE). The time domain RTE is 
[51]~[54]
: 

















         Equation 13 
where cm is the velocity of light in the medium,  tsr ,ˆ,  is the number of photons per unit 
volume at position r and time t with velocity in direction ŝ .  ss  ˆ,ˆ  is the normalized 
scatter phase function giving the probability of photon scattering from direction ŝ  to sˆ . 
 tsrq ,ˆ,  is the light source at r and time t travelling in direction ŝ . ŝ  is a normalized 


















ŝ             Equation 14 
The transport cross section µtr(r)=µa(r)+µs(r), where µa(r) and µs(r) are the 
absorption cross section and scattering cross section at position r accordingly. 
RTE describes that the radiance at position r and direction ŝ  equals to the sum of 






, the frequency domain RTE can be derived as: 
















        Equation 15 
Since the RTE does not consider the wave effects, its application is focused on the 
wavelength much smaller than the dimensions of the study object. In optical tomography, 
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the solution for the light field at points in large 3D volume is extremely computationally 
expensive which motivates the need to develop a simpler model.  
By using the spherical harmonics Yn,m the radiation  and source term q in time 
domain expression can be expanded as 
[53]
: 










mnmn sYtrtsr            Equation 16 







mnmn sYtrqtsrq ˆ,,ˆ, ,,          Equation 17 
The term for n=0 and m=0 represents the isotropic component, while the terms 
n=1 and m=0, ±1 are the anisotropic components. The larger the n becomes, the more 
accurate the approximation model is, but the computational expense will be increased 
quickly. When applying P1 approximation and the assumption that the photon flux 
changes slowly and the light source is isotropic, the RTE becomes the following 
equations: 















          Equation 18 
and 
 

















         Equation 19 
where the photon density     sdtsrtr ˆ,ˆ,,  and photon current     sdtsrstrJ ˆ,ˆ,ˆ,   
The diffusion approximation gives the assumption that the scattering is a 
dominant effect when light propagates in the medium, implying that sa    and 







 and q1=0,    trDtrJ ,,   
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Then the diffusion equation can be derived as: 













         Equation 20 
and the frequency domain form can be expressed as: 
           

 ,,,, 0 rqr
c
i
rrrr a         Equation 21 
where к(r) and µa(r) are the diffusion coefficient and absorption coefficient respectively, 
and are functions of the position r. 
2.4 Imaging reconstruction 
The imaging reconstruction method used in this study is based on the software 
package called ―Near Infrared Fluorescence and Spectral Tomography (NIRFAST)‖ 
which was developed by Dartmouth NIR Imaging research group. NIRFAST calculates 
the data acquired from the frequency domain measurement 
[55]
. 
In the forward model, the frequency domain diffusion equation (Equ.21) was 
applied to calculate the photon fluence rate Φ at position r with modulation frequency ω 
based on the finite element method (FEM). The fluence rate Φ(r) can be approximated as 
[53]~[55]: 









            Equation 22 
where Ω
h
 is a finite dimensional subspace spanned by basis functions {ui(r), i=1…V} 
chosen to have limited support. Then the diffusion equation in the FEM framework can 






















































    
 rdruruF njiji
1
, , and 




At the boundary, NIRFAST adopts the type III boundary condition (known as 
Robin boundary condition) representing the boundary between air and tissue. The fluence 
at the tissue boundary exits but does not return. The flux leaving the external boundary is 
equal to the fluence rate at the boundary weighted by a factor that accounts for the 
internal reflection of light back into the tissue 
[55]
: 
      0,ˆ2,   nA           Equation 24 
where ξ is a point on the external boundary, n̂  is the outward pointing normal and A 





























































Since those matrices K, C and F are sparse, the solution can be obtained by 
standard methods such as Cholesky reduction, substitution or biconjugate gradient in the 
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The inverse problem is to solve the optical properties µa(r) and D(r) at each FEM 
node. Assuming n×2 vector  Dx a , , the objective of the inverse problem is to find 
the solution which minimizes the difference between the measurement and the 
calculation of the forward model based on Equ.23. The least square is the generally 
applied to seek the minimization of the residue 
[55][56]
: 
min(Ψ):        mcmcmc xxx 
2





 are the calculated and measured optical fluence. In order to avoid the 
ill-conditioned and singular matrix that could give non-unique solutions, Tikhonov 





xxx mc            Equation 27 
where λ is regularization factor defined as the ratio of the variances of the measurement 







  , and x0 is the initial estimate of the optical properties 
which can be obtained from data calibration or a priori optical properties distribution. By 
taking the first order derivative of the objective and ignoring those higher order terms, 
Equ.27 becomes: 






















 is known as the Jacobian matrix J referring to the weighted or sensitivity 
matrix. In NIRFAST, which is a frequency domain imaging reconstruction algorithm, the 
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      Equation 29 
where M is the number of measurement and N is the FEM mesh nodes. With Jacobian 
Matrix, the Equ.28 could be replaced by following equation: 
   0xxJxIJJ iTT             Equation 30 
Assuming 0xxx i  , then Equ.30 becomes: 
    TT JxIJJ 2             Equation 31 








          Equation 32 




2.5 Continuous wave steady-state measurement 
With the development of the analytic or numerical model of the DOT theory, 
there are several different measurement techniques which have been applied in DOT. The 
first is time-domain measurement provides information on the increased path length of 
light in tissue due to multiple scattering events, thus improving the ability to separately 
recover absorption and scattering properties 
[57][58]
. The second is frequency-domain 
measurement, when the phase shift of a sinusoidal wave passing through a tissue volume 
is recorded, provide a less expensive and perhaps stable manner of acquiring time-based 
information 
[59][60]
. The third one called Continuous Wave steady-state measurement uses 
the DC light source and directly measure the attenuation of the light power 
[61]~[63]
. It was 
applied in the DC-based imaging reconstruction algorithm. Although time-domain and 
frequency-domain based methods may provide more optical information than CW 
approaches, a number of researchers have been interested in CW image reconstruction for 
several years, in part because of the relative simplicity, high signal-to-noise ratio, and low 
cost of CW techniques 
[64]
. Recent studies have demonstrated that absorption and reduced 
scattering coefficients can be reconstructed quantitatively from steady-state 
measurements, by updating the D and a  distributions to minimize a weighted sum of the 
squared difference between computed and measured data 
[65]~[67]
. The method is 
equivalent to performing the same minimization as Equ.27 by mapping the DC signal to 
frequency-domain, which has been utilized in the reconstruction of this study. A recent 
study showed that, when appropriate de-convolution is applied, CW data appears to 
provide significantly better spatial resolution than frequency-domain data. To date, 
significant progress in CW DOT has been made with both phantom and in-vivo clinical 
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data which suggests that research of CW DOT should be performed parallel to that of 
other methods. 
In the continuous wave (CW) steady state measurement, ω=0, the diffusion 







            Equation 33 
For infinite homogeneous medium and semi-infinite medium, the diffusion 




























          Equation 35 
where 
22
ar Rl   ,  






, Rb=2AD and ρ is the physical 
distance between the source and detector. 
In inverse problem, the iteration follows the calculation same as the Equ.32. Since 
there is no phase information, the Jacobian matrix only includes the amplitude related 
items which becomes Equ.36 while the absorption coefficient and D are still both updated 
































































































      Equation 36 
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2.6 Optical measurement of prostate 
The optical measurement of the prostate was initialized in the 1980s which mainly 
focused on the initial work on photodynamic therapy (PDT) by interstitial optical 
measurement. In the 1990s, an intraluminal fiber reflectometry was introduced for 
prostate measurement which made it possible for the internal noninvasive measurement 
of optical properties. The measurement compared the human prostate and dog prostate 
optical absorption and scattering within the wavelength from 650nm to 750nm. There 
have been a number of studies on prostate optical properties which have been 
summarized by Svensson in 2007 and Piao in 2009. Although these studies were 
conducted at different wavelengths, different samples and different methods, they offered 
invaluable information to understand the potentials of detecting prostate cancer and 
difficulties in terms of the prostate optical measurement 
[68]~[72]
. The previous studies on 
the human prostate optical absorption, reduced scattering and effective coefficient are 





Table 2 Human prostate optical properties (cm
-1
) 





 in-vivo, CW, untreated PC 630 7   3.5±0.7 
Pantelides 
[74] 
ex vivo, CW, normal whole 
prostates 
633 3 0.7±0.2 8.6±0.5 4.3±0.5 
Whitehurst 
[75] 
in-vivo, CW, untreated BPH 
and PC 
633 11   3.6±0.2 
Lee 
[76] 
in-vivo, CW, untreated BPH 
and PC 
633 11   3.9±0.5 
Wei et al. 
[77]
 in vitro, CW, BPH 640 29 8.85~9.55 15.6~16.6  
Svensson 
[71]
 in-vivo, TD, untreated PC 660 9 0.5±0.1 8.7±1.9 3.6±0.8 
Lee 
[76]
 in-vivo, CW, untreated BPH 
and PC 
665 11   3.2±0.5 
Zhu 
[78]
 in-vivo, CW, recurrent PC 732 13 0.4±0.2 11.8±8.2 3.3±0.5 
Zhu 
[79]
 in-vivo, RC Pca 732 2 0.11~1.6 1.2~40 0.19~6.3 
Li 
[80]
 in-vivo, 2D map, RC Pca 732 1 0. 1~1 5~45  
Wang 
[81]
 in-vivo, 3D map, RC Pca 732 1 0.1~0.7 1~55  
Weersink 
[82]
 in-vivo, CW, recurrent PC 762 22 0.4±0.2 3.4±1.6 2.0±0.6 
Svensson 
[71]
 in-vivo, TD, untreated PC 786 9 0.4±0.1 7.1±1.6 2.9±0.7 
Svensson 
[71]
 in-vivo, TD, PCa 830 1 0.34 2.5~10  
Wei 
[77]
 in vitro, CW, BPH 880 29 4.43~4.55 11.2-12.0  
Svensson 
[71]
 in-vivo, TD, untreated PC 916 9 0.6±0.1 7.7±1.8 3.8±0.8 
Sevensson 
[50]
 in-vivo, TD, Pca 916 1 0.42 6.4  
Essenpreis 
[83]
 ex vivo integrating sphere data, 
normal prostates 
1064  1.5±0.2 6.4  
Roggan 
[84]
 ex vivo, Normal 1064  0.03 0.4 0.2 
 
In Table 2, CW means steady state data and TD is time resolved data. BPH is the 
benign prostatic hyperplasia and PC indicates the prostate cancer. All the measurements 
were performed invasively, and some of studies were aimed to measure the effective 









  3           Equation 37 
Previous research has demonstrated that the optical reduced scattering coefficient 
of prostate is around 10 times higher than prostate optical absorption coefficient which 
indicated that prostate can be considered as an optical scattering dominant tissue. The 
photon propagation in prostate can be modeled by the diffusion equation described in 
Equ.20 and Equ.21. 
Studies also found the significant intersubject and intraorgan heterogeneities of 
human prostrates, different separation of the source and detector of PDT would give a 
different measured optical properties of absorption and scattering. The intraorgan 
heterogeneity gives a substantial challenge to differentiating malignant tissue from 
normal tissue and may also partially contribute to the similar effective attenuation 
coefficients of benign and malignant human prostate tissues 
[85]
. 
It must be noted that none of the previous measurements of prostate optical 
heterogeneities have been examined on intact prostate in-vivo. In order to demonstrate if 
or which type of intrinsic optical property contrasts could be useful for differentiating the 
malignant prostatic tissue from benign or normal tissue, a system which aims at imaging 








There are several NIR tomography applicators designed for the brain imaging and breast 
imaging that employed well designed spherical or ring type NIR imaging probes. Prostate 
imaging requires different types of applicator as it is an internal organ in human body. 
The common size of the prostate is only 50mm along the maximum dimension which is 
much smaller than brain or breast as well. The feasible way to imaging prostate for NIR 
optical tomography is through the rectum while it brings some unique challenges 
particularly for the fabrication of an endo-rectal NIR applicator, which is more 
challenging if it is integrated with TRUS probe. First, the combination with ultrasound 
imaging system renders accurate and real-time anatomic information to correlate NIR 
optical system. The structural information obtained from TRUS may further provide the 
required a priori information to improve the accuracy of NIR image reconstruction; 
second, the axial dimension of the probe is restricted within 20~30mm (diameter). 
Thirdly, TRUS-coupled endo-rectal NIR applicator requires deploying many optodes in a 
very limited space. It has been suggested that arranging optodes longitudinally is an 






3.1 Trans-rectal optical imaging applicator 
According to the simulation study of different optode configurations on the trans-
rectal imaging geometry, a proto-type of the combined TRUS coupled trans-rectal NIR 
imaging probe was fabricated by parallelly deploying 7 by 7 optical source and detector 
channels. The integrated sagittal-imaging trans-rectal NIR/US applicator consists of a 
custom-built NIR probe and a commercial bi-plane TRUS transducer (for canine prostate 
imaging), as shown in Fig.9. The bi-plane TRUS probe was equipped with a proximal 
7.5MHz sagittal-imaging transducer and a distal 5MHz transverse-imaging transducer. 
The sagittal TRUS transducer occupies a 60mm×10mm window. The diameters of the 
sagittal and transverse imaging sections of the TRUS probe are 18mm and 20mm, 
respectively. Adapting to the un-even TRUS cross-section, the NIR applicator was 
fabricated to a cap-shape and attached to the TRUS probe (Fig. 9(a) ~ (e)). The NIR array 
substrate was machined from a black polycarbonate material to minimize the surface 
reflection. This substrate was then connected to an aluminum bracket and securely 
fastened to the TRUS handle using a bottom clamp. The rectangular TRUS handle (Fig.9 
(f) ~ (g)) ensured aligning the NIR applicator to the TRUS transducer. A slot of 







Figure 9 Design of combined trans-rectal US/NIR probe 
 
The NIR probe consists of two linear-arrays, one for the source and the other for 
the detector, separated by 20mm and placed on each side of the sagittal TRUS transducer. 
Each linear-array consists of 7 channels spaced 10mm apart and covering 60mm in 
length. The 60mm long NIR array is aligned precisely with the 60mm window of the 
sagittal TRUS transducer. 
A 600µm-core diameter (750µm with metal coating) fiber (Oxford Electronics HP 
SIR 600CB) is chosen for its thin cladding and mechanical strength. The 7 fibers of each 
linear-array are packaged into one groove of ~4mm4mm in cross-section formed in the 
black substrate. Bending the fiber inside the small groove for side-firing at the probe 
surface is impractical. The minimum bend radius of this fiber for long term is 100 times 
of fiber radius which is 75mm (for short term is 40 times of the radius which is 30mm). 
Instead, micro-optics components were used for deflecting the light side-ways. As shown 
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in Fig. 10, each source channel includes 2 gradient-index (GRIN) lenses and 1 prism 
attached to the fiber while each detector channel has 1 GRIN lens and 1 prism attached to 
the fiber. The GRIN lens (Newport Corporation) has a pitch of 0.25, a diameter of 1mm, 
a length of 2.61mm, and a numerical aperture of 0.46. The prism is a coated 1mm right 
angle micro-prism with enhanced Aluminum coating on hypotenuse (Tower Optics) with 
reflection efficiency around 80%. Each fiber is polished and epoxied to a prism and a 
GRIN lens is attached to the other side of the micro-prism for illumination and detection 
at the probe surface. In this micro-optics assembling, under the monitoring by 
microscope, each piece was aligned accurately with other optical parts by home-designed 
stages and mounts with 3-dimension freedom for GRIN lens & Micro-prisms. The epoxy 
(NORLAND 81) with a viscosity of 300cps is hard and resilient. After curing, the epoxy 
has a refractive index of 1.56 and good adhesion to glass, metals and glass filed plastics. 
The optimum adhesion reached after room temperature aging for one week and it can be 
accelerated by aging at 50°C for 12 hours. 
 
Figure 10 Micro-optics assembling of on-probe optical channels 
 
As depicted in Fig. 10, each source channel has one GRIN lens attached to the 
proximal end of the fiber for coupling the light. The GRIN lens has larger diameter and 
numerical aperture than the metal-coated fiber that is expected to give a higher coupling 
efficiency for collimated light. Simulation by ZEMAX (ZEMAX Development Co.) 
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showed that for collimated incident beam using a GRIN lens and a prism gives 38% more 
coupling than without the GRIN lens (assuming micro-prism has 80% reflection at NIR 
band that is typical for enhanced aluminum coating). A coupling efficiency improvement 
of 10%~15% is observed experimentally from the completed fiber channels. The overall 
coupling efficiencies of the 14 home-assembled fiber channels are shown in Table 2. The 
overall coupling efficiency of each channel is about 50%, which could be improved if the 
assembly can be made more precise. 
Table 3. Measured coupling efficiency of the source/detector fiber channels 
Source channels s1 s2 s3 s4 s5 s6 s7 
Coupling efficiency 46% 48% 49% 49% 51% 43% 49% 
Detector channels d1 d2 d3 d4 d5 d6 d7 
Coupling efficiency 54% 48% 49% 51% 53% 52% 50% 
 
In the optical system design, there are two set up of optical systems that have been 
used for different application from system calibration to clinical application. One is 
called spectral-encoded system which was mainly used in experiments of system 
calibration for its highs speed data acquisition; the other is a source switching time-
multiplex optical system which was applied during in-vivo animal experiments because 






3.2 Spectral-encoded imaging system 
 
Figure 11 System diagram 
 
In the system calibration, we use the spectral-encoded optical imaging system 
[92]~[94]
 which has a relative short data acquisition time (<200ms for most of the known 
value solid phantom experiments). The combined trans-rectal NIR/US imager is 
schematically illustrated in Fig. 11 and the photograph is given in Fig. 12. The US 
scanner is an ALOKA SSD-900V portable machine. The US images are transferred to the 
main computer of the combined imager by a PCI image acquisition card (National 
Instruments PCI-1405). For ALOKA SSD-900V US system, the calibrated US scanner 
range in longitudinal dimension is 50mm which corresponded to the optical channels 
from source/detector 1 to source/detector 6. 
The NIR imager uses a custom-designed superluminescent diode (SLD) 
(Superlumdiodes Inc.) that is pigtailed to a multi-mode fiber and delivers 100mW of 
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840nm NIR light with 14.2nm FWHM bandwidth. In the schematic of Fig. 11, the SLD 
output beam is dispersed by a 1200 groves/mm grating. As described by Equ.37, different 
wavelength light will be dispersed into different directions and collimated unto linearly 
aligned 7 fibers connecting to the source channels on NIR applicator. 
   md  sinsin            Equation 38 
Where d is the period constant of grating (1/1200 mm
-1
), α and β are the incident 
and output angle of light (respected to the normal of the grating), m is the order of the 
diffraction (0 means the none dispersed light beam/ specular reflection beam). 
NIR light with slightly different wavelengths are coupled to the 7 fibers to form a 
spread-spectral-encoding of the source channels. In this system configuration, one source 
channel coupled around 1nm bandwidth light which centered at 840nm. The remitted 
lights collected by the 7 detection channels are coupled to a spectrometer (Acton 
Research 2300i). The signal corresponding to the individual source channels are 
discriminated horizontally by the spectrometer (1/1200 mm
-1
 grating). The signals 
corresponding to the individual detector channels are differentiated vertically based on 
the position of the detection channels on the spectrometer entrance slit. A 16-bit 
intensified CCD camera (Princeton Instruments PIMAX) acquires a complete set of NIR 
imaging data. The exposure time for one frame of data is in the range of 100s 
milliseconds, depending on the medium being imaged. When controlled by the software 
of Winspec, the CCD data acquisition time is set to the default value at 300ms. The NIR 




Figure 12 Spectral-encoded imaging system and photograph 
 
The spectrometer (SpectraPro 2300i) has a focal length of 300mm-f/3.9. It has 
three different grove grating mounted in a rotational stage. The different resolutions of 
the different gratings are listed in Table 3: 
Table 4 Parameters of SpectraPro 2300i 





The CCD was PI-MAX from Princeton instruments. It has a stand-alone 
controller ST-133 offering a data transferring at speed of 5M pixel/second and standard 
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video output for focusing and alignment. The basic parameters of the CCD are shown in 
the following table 4: 
Table 5 Parameters of CCD 










<8 e- rms@100kHz 
<35e- rms@1MHz 
<50e- rms@5MHz 
1 to 80 
ADU/photoelectron 
 
The CCD was air cooled down to ~-20°C to reduce the amount of dark charge, 
which can improve the signal to noise ratio. The minimum value of the CCD image 
readout intensity is around 70 (Maximum is 65535), while the averaged value over one 
frame image (512×512) is around 90~100. 
The 16bit CCD has a maximum dynamic range of 48dB, which may not be 
sufficient to accommodate the full dynamic range of the signals when a medium is highly 
absorptive, as the minimum and maximum source-detector distances of the trans-rectal 
NIR array are 20mm and 63mm, respectively. Reducing the total dynamic range of the 
signal is possible by proper use of the Gaussian spectrum of the SLD source. The actual 
light coupling configuration is given in Fig. 13(a), where the stronger spectral 
components are coupled to the peripheral NIR channels (such as 1 and 7), and the weaker 
spectral components are coupled to the middle NIR channels (such as 3-5). Comparing 
with the configuration of coupling the uniform light to all 7 source channels, the strategy 





 absorption coefficient and 1.0mm
-1
 reduced scattering coefficient (equivalent 
to a 1% Intralipid solution) in Fig. 13(b). 
 
Figure 13 Spectral-encoded source coupling sequence 
3.3 Switching-source optical imaging system 
In the previous spectrum-encoded optical imaging system, the coupled light 
power efficiency with respect to the SLD output will be no higher than 40%. It mainly 
comes from the grating dispersion (~60% reflective efficiency at 1st order) and the lost 
light spectrum and the specular reflection cannot be coupled into source channels unless 
using some special designs. The averaged light power coupled in each optical channel is 
around 5mw. In the system calibration tests which mainly used the 1% intralipid as 
background, the coupled light power was acceptable which had an exposure time in the 
range of 100ms. When it is moved on to the tests of high absorptive bio-tissue like canine 
or human prostate (µa~0.01mm
-1
), the acquisition time was much longer (>4s) in order to 
get the weakest signal. The longer data acquisition time will not only extend the 
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experiment time but also introduce strong noise into the measured data interfering the 
signals especially for those weak channels. In order to minimize the test time in the 
examination and improve the signal-to-noise ratio, strong light power was expected for 
each source channel. In Fig. 14, we coupled the entire SLD source power (100mw) into 
one source channel. A translation linear stage (Zaber Technologies) was used to switch 
the SLD light sequentially along the source channels from 1 to 7. The measured coupling 
efficiency of the switching setup before the source channel is over 95%. The exposure 
time at each source switch position is minimized to 100ms. The total test time with 7 
channel switching is no more than 3 seconds which mainly relied on the readout time of 
CCD with a typical value of 309.6ms for each frame. The detection components of the 
system in Fig.14 are the same as previous spread-spectrum-encoded system described in 
section 3.2. 
 
Figure 14 Switching source coupling system 
 
The source switch was mainly built on a linear motorized slide (T-LSR 75B series 
from Zaber technologies Inc.). It has a built-in controllers and RS232 computer-interface 
with manual control. The maximum travel distance is 75mm and the maximum centered 
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load is 200N (44.9 lb.). The accuracy of the position is ±8µm while repeatability is 
<2.5µm. The liner stage is controlled by Labview8.5 program and the resolution of the 
minimum controllable step is 0.496µm. The translational slide is photographed in Fig. 15. 
 
Figure 15 Photography of switching coupling system setup 
 
The synchronization of the movement of the translation stage and CCD 
acquisition is the most important part in this time-multiplex switching system set up. Fig. 
16 sketches the controller system diagram in which the CCD data acquisition is 
controlled by the software of Winspec by accepting the outside trigger signal. The 
triggered signal was generated by a DAQ/PCI card from the Labview program which 
controlled the translation stage movement. 
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PCI-6251 is a 16bit data acquisition card which has a sampling clock speed at 
1MHz (multichannel)/1.25MHz (single channel). There are 16 differential/single-end 
analog input ports and 2 output ports. 
The US scanner was also controlled by Labview to acquire and save the US 
images coupled to NIR images. The real-time ultrasound image was obtained by PCI-
1405, single-channel color image acquisition (IMAQ) device, through a BNC cable 
connected with the output of the US scanner (Aloka US 900). The video output of the 
ultrasound scanner is the NTSC stream at 30 frames/s speed. 
 
Figure 16 Design of control system 
 
Each position of the motor-stage staying for coupling the light into each source 
channel was calibrated with maximum coupled light power and was saved in a text file. 
In Fig. 17, the Labview program firstly loaded the text file including those 7 positions 
that the linear stage was going to switch then started to move. When the stage arrived at a 
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position, it gave a response to Labview of this arrival that triggered the data acquisition 
(DAQ) function to generate the TTL signal to start the CCD data acquisition process 
which was controlled by Winspec with a pre-defined exposure time. After the CCD got 
one frame image of data, Labview instructed the linear stage to move to next the position. 
Those commands were iteratively processed for 7 times. 
 
Figure 17 Labview program of system control 
 
The operating interface of the Labview is shown as the following Fig. 18. Each 














The combined US/NIR probe and system enables concurrent acquisition of trans-rectal 
NIR tomography and TRUS images on the same sagittal plane. The system was first 
calibrated by known value phantom experiments and further demonstrated by tissue 
sample tests. Previous studies also have validated that incorporating TRUS a priori 
information allows trans-rectal NIR tomography to recover an absorption target 
accurately. In this chapter, it was first demonstrated that trans-rectal NIR imaging could 
recover an absorptive target without spatial prior. When incorporating the a priori 
information, the system performance was quantified with accurate reconstruction of 
target absorption. In tests, 2-dimensional TRUS image was used to locate a suspected 
TVT target, and NIR optical tomography allowed 3-dimensional imaging. The 
geometrical relation of the 2D ultrasound image and 3D optical image was shown in Fig. 
19. The ultrasound imaging plane was right at the middle-sagittal plane of the 3D optical 
imaging volume. Most of the later optical images were taken at this plane for the 






Figure 19 Imaging geometry of the 3D optical reconstruction and 2D US image 
 
In the system performance testing, the calibration will be a first step which is a 
very important procedure to caliper the system response from steady-state continuous 
wave (CW) measurement to minimize the effects from the variation of optical source 
power, background noise of CCD detection, the coupling difference among those optical 
channels such as the characteristics of each optical fiber, grin lens and prism. In this 
combined system calibration, the performance of known value solid phantom imaging by 
the endo-rectal NIR applicator was evaluated in order to quantify the system response. 
The solid phantom was fabricated from a bulk material that was provided and calibrated 
by the NIR optical imaging laboratory of Dartmouth College. The phantom (Fig. 20a) 
was machined to a cylinder-shape with 15mm in diameter and 25mm in length. It has a 
measured absorption coefficient of 0.0056mm
-1
 and a reduced scattering coefficient of 
1.03mm
-1
. The target was put into a tank which was filled with 1% intralipid with an 
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 of reduced optical scattering. 
The testing set up was depicted in Fig. 20(b). The target was mounted on the 3-axis 
freedom stage which can be displaced in 3 dimensions with respect to the fixed trans-
rectal NIR optical imaging probe. 
 
Figure 20 Solid phantom and experimental set up 
 
From the description in section 2.4, the initial guess was very important for the 
imaging reconstruction. Accurate background absorption was expected in the system 
calibration for the performance quantification. Several test results of the homogeneous 
intralipid background with different absorptions added by diluted ink were measured by 
spectrophotometer as shown in Appendices 1. The following background absorptions 
were obtained from those results. 
4.1 Semi-infinite boundary condition 
In the known value phantom system calibration, the spectral-encoded optical 
system gave a raw data acquired by CCD of the spectrum-encoded optical imaging 
system shown in Fig. 21(a). If the SLD spectral components were coupled orderly to the 
source channels from 1 to 7, the higher intensity signals would have been located along a 
48 
 
diagonal line in the CCD acquired image. As previous discussed in Section 3.2, the 
source coupling sequence from the short wavelength to long wavelength is source 4, 3, 2, 
1, 7, 6, 5. Each row represents the detected 7 signals of one detection channels along 7 
different wavelengths, and each column indicates how much power of each source 
channel coupled to 7 detector channels. The modified source coupling configuration 
described in Fig. 13 leads to the pattern of diagonal-shifted high-intensity signals as 
shown in Fig. 21(a) which was taken from a homogenous 1% intralipid background with 
0.0023mm
-1
 absorption and 1.0mm
-1




Figure 21 Spectral-encoded system data calibration 
 
Our imaging probe is a slab shape that was put with a cylinder shape trans-rectal 
ultrasound probe. Recent study on the convex geometry gave an analytical solution of the 
photon density which can be simplified at large radial dimension and longer source-
detector distance (>20mm). The simulation results showed that it can be approximately to 
the semi-infinite boundary condition. For a collimated source and a detector at a semi-












































      
Equation 39 
where ρ is the source-detector distance, and zb is a length term determined by the 
refractive index mismatch on the boundary. The linear relationship between   )(ln 2  U  






























lnln       Equation 40 
Fig. 21(b) showed one calibrated data set corresponding to the complete 77 
source-detector pairs is displayed. And in fig. 21(c) gave a comparison between the 
calibrated data and non-calibrated one. The slope derived in Equ.39 could be defined by 
the effective attenuation coefficient which is expressed by Equ.36 in previous Section 
2.6. 
4.2 Stand-alone optical reconstruction 
 




Figure 22 lists the images reconstructed with stand alone optical reconstruction 
method which has been described detail in previous Section 2.4. The FEM based 
reconstruction used a mesh of homogenous density throughout the entire NIR imaging 
volume. The optical properties are certainly updated element-by-element in order to 
recover the heterogeneity being imaged. The solid phantom is placed at the mid-sagittal 
plane. The NIR images are displayed with a field of view of 80×30mm
2
. The left most 
optode is located at 10mm right to the left edge of the image, and the right-most optode is 
10mm left to the right edge of the image. The (a), (b), and (c) correspond to the target 
depth of 17.5mm at longitudinal locations of 20, 40 and 60mm (counted from left edge), 
respectively. The (d), (e) and (f) correspond to the phantom depth of 12.5mm at 
longitudinal locations of 20, 40 and 60mm, respectively. The target is identified clearly 
against satisfactorily recovered background; however, the absorption contrast of the 








Figure 23 Normalized reconstructed absorption value vs. different longitudinal positions. 
 
Figure 23(a) describes the contours of the normalized reconstructed absorption 
value. Fig. (b) and (c) depict the normalized absorption contour at three longitudinal 
locations with different depth accordingly (b) 12.5mm and (c) 17.5mm. At lower depth 
(b), the contour width is quite narrower than (c) and the peak value is higher than (c) 





Figure 24 Normalized reconstructed absorption value vs. different target depths 
 
Another contour in one target depth was described in Fig. 24(a). The horizontal 
axis is the normalized absorption value and the vertical axis is the depth in millimeter 
unit. (b), (c) and (d) are corresponding to the three longitudinal displacements (x=20, 40 
and 60mm) in Fig. 23. It shows only a little differences of the peak when the target was 
moved from 12.5mm to 17.5mm. The deeper target seems to be reconstructed at the same 
longitudinal location but with lower recovered absorption value at lower imaging depth. 
Figure 25 gives a simulation results at the coronal plane and axial plane when the 
solid phantom was displaced in the middle-axial plane. In simulation the target was a 
spherical shape with 10mm in diameter. In the reconstructed optical images, the dash 
circled area corresponds to positions of the target in coronal or axial plane. The 




Figure 25 Simulation results when target was displaced in the middle-axial plane 
 
Because of the difficulty of the fabrication of a spherical target, in the 
experiments, it was replaced by a cylinder shape with 10mm in diameter but 20mm in 
length. Also, the dashed area in the reconstructed axial and coronal plane is the location 





Figure 26 Measurement of the displacement of the target in middle-axial plane 
 
Comparing those simulation and testing results from Fig. 22~ Fig. 26, the system 
response when a target moved in the sagittal plane was much sensitive than it moved in 
the axial and coronal plane. This sensitivity problem comes from the inherit 
reconstruction algorithm discussed in Section 2.4 and also an effect of the probe 




(a) Longitudinal sensitivity   (b) Lateral sensitivity 
 
(c) Depth sensitivity 
Figure 27 Sensitivity profile of 7 by 7 source-detector optical channel deployment 
 
Figure 27 gave a sensitivity profile calculated by projecting the Jacobian values 





. The probe occupies a length of 60mm from 10mm to 70mm in (a). In the 
center part of the probe from 20mm to 60mm corresponds to the source/detector 2 to 
source/detector 6. The variation of the sensitivity is about 5dB, while in lateral and the 
depth sensitivity, the displacement of 20mm gives a 20dB changes. This sensitivity 
analysis explains why in the sagittal plane, the position correlation of reconstructed 





4.3 Imaging reconstruction with a priori information 
In NIR breast cancer imaging studies, it is found that by incorporating a priori 
information, the optical imaging will be improved both in high imaging resolution and 
accurate reconstructed optical coefficients. By extending this method to this trans-rectal 
prostate NIR imaging study, imaging reconstruction with prior is described in Fig. 28. 
The location and the size information of the target obtained from US image were used to 
generate a dual-density mesh with two regions of background and suspicious area. Both 
the optical properties of absorption and scattering are set to be homogenous in those two 
regions (background and ROI). In this case, the Jacobian matrix in CW (Equ. 35) 




































































          Equation 41 
Where the notation 1 and 2 indicate the region of the homogeneous background 
and interested. In the iteration, there are only 2 sets of different optical properties updated 
in each round. The dramatic decreased variables make the reconstruction value become 






Figure 28 Reconstruction with spatial a priori information 
 
In Fig. 28 simulation, the NIR image reconstruction uses a 3-dimensional mesh 
representing 804060mm
3
. The NIR image is reconstructed and displayed at the mid-
sagittal plane to correlate with TRUS image. The absorption coefficient is correctly 
recovered with this a priori information. The image reconstruction typically takes ~10 
minutes on a 3.0GHz Pentium(R) 4 PC for 10 iterations. 
The same data sets in Fig. 22 were reconstructed in Fig. 29 using the target a 
priori information obtained from TRUS. The TRUS image, similar to the one in Fig. 
28(b), has artifacts around and shows only the lower half of the cylinder owing to the 
shadow effect. This image/artifact pattern is specific to the solid cylinder target that 
reflects much of the US signal on its surface. This type of artifact may not be 
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representative for tissue imaging in situ. The artifact is thereby ignored when 
incorporating the spatial information of the target, by generating a mesh having a 
homogenous background region and a circular target region as shown in Fig. 28(c). As 
there are only two regions to reconstruct, the hierarchical iteration routine involves only 
2-steps. The reconstructed values are given in Table 6. The absorption coefficient of the 
background medium is reconstructed at 0.002mm
-1
 for all images and the target is 








Table 6. NIR image reconstruction guided by TRUS spatial prior 
Center depth 12.5mm 
Longitudinal location (x) 20mm 40mm 60mm 
True Value (mm
-1
) 0.0056 0.0056 0.0056 
Reconstructed value (mm
-1
) 0.0067 0.0064 0.0063 
Center depth 17.5mm 
Longitudinal location (x) 20mm 20mm 20mm 
True Value (mm
-1
) 0.0056 0.0056 0.0056 
Reconstructed value (mm
-1
) 0.0064 0.0063 0.0061 
 
4.4 Imaging of dual targets 
The capability of recovering more than one target by the endo-rectal NIR probe 
was also examined. Two cylinder-shaped solid tissue phantoms, including the one shown 
in Fig. 20, were used as the target. Both targets were 15mm in diameter and 25mm in 
length. The newly added solid phantom has an absorption coefficient of 0.0064mm
-1
 and 
a reduced scattering coefficient of 0.91 mm
-1





. Fig. 30(a) and (b) are the images for placing the two targets at 
depths of 17.5mm and 22.5mm, respectively, in the mid-sagittal plane, with 20mm 
longitudinal spacing. When the reconstruction is performed without the target spatial 
information, the two targets can barely be differentiated at the depth of 17.5mm by the 
normalized contour same calculated as section 4.2, and not discriminated at the depth of 
22.5mm. The absorption contrasts of the targets are also significantly underestimated and 
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overlapped in both cases. Fig. 30(c) indicates the results of using the spatial information 
from the TRUS image. The two targets can be recovered as having different absorption 
contrasts at both depths. The reconstructed absorption coefficients listed in Table 7 are 
also close to the true values. 
 
Figure 30 Imaging of dual targets using solid phantoms 
 
Table 7 Reconstructed absorption coefficients with spatial prior 
Target optical absorption Target 1 Target 2 
True value (mm
-1
) 0.0064 0.0056 
Reconstructed value (mm
-1
) 0.0067 0.0058 
 
4.5 Effect of condom 
The TRUS probe is always covered with a regular latex condom when imaging 
the prostate. Therefore the TRUS-coupled NIR applicator has to be applied with a 
condom if used in the clinic. In the previous applications of NIR tomography imaging 
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there was no need of applying a latex barrier between an NIR applicator and the tissue 
being interrogated, therefore the effect of a latex condom on NIR tomography was not 
reported which was firstly reported in this study. 
The test being carried out used the setup and solid phantom shown in Fig. 31, by 
applying US gel to the NIR/US probe, covering the NIR/US with a condom, and then 
pressing the condom to eliminate any gas between the condom and the probe. US gel is 
not applied on top of the condom when imaging the intralipid, but is applied for all the 
tissue imaging tests presented in Section 4.6~4.9. The absorption coefficient of the target 
reconstructed using TRUS information is listed in Table 8. The overall distribution of the 
reconstructed absorption coefficient of the target is plotted in Fig. 31(b), and the 
distribution specific to target position is plotted in Fig. 31(c). These results, which are 
consistent with those presented in Table 6, demonstrate that the condom has minimum 
effects on NIR imaging. Nevertheless, an attenuation of the light power is observed, as it 
takes 10% longer exposure time for CCD to integrate the same amount of signal when the 




Figure 31 Condom effect measured from solid phantom 
 
Table 8 Absorption coefficient reconstructed with the use of condom (mm
-1
) 
Depth (mm) 22.5 25 27.5 30 32.5 35 37.5 
True value 0.0056 0.0056 0.0056 0.0056 0.0056 0.0056 0.0056 
X=20mm 0.0065 0.0058 0.0070 0.0066 0.0048 0.0043 0.014 
X=40mm 0.0053 0.0051 0.0047 0.0049 0.0043 0.0052 0.0063 






Figure 32 a priori reconstruction images of condom tests 
 
The reconstructed images corresponding to Table 8 are listed in Fig. 32. The tests 
in Fig. 32 represent the most favorable conditions in which there is only one target in an 
otherwise homogenous medium. For the given condition in Fig. 32 the target can actually 
be recovered at depth up to 40mm when it is located at the longitudinal center of the 
probe. This is not unexpected as the maximum longitudinal sensitivity occurs at the 
center of the probe, and the lower edge of the tissue phantom is actually 32.5 from the 
probe surface. When the tissue phantom is moved to either longitudinal side of the probe, 
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the imaging depth degraded to 30~35mm, which is apparently due to the degraded 
sensitivity at the probe edges. 
4.6 Imaging solid absorbing object embedded in avian tissue 
The condom-covered NIR/US probe was enclosed within thick layers of chicken 
breast tissue 1006.0  mma , 
1757.0  mms , and a black object (10mm diameter 
10mm length) was embedded as a high absorptive target. The photographs in Fig. 33(a) 
and (b) show the setup of tissue sample and the absorbing target being embedded. The 
tissue without the absorbing target is also imaged as a baseline test. The baseline images 
by US and NIR are shown in Fig. 33(c), where the NIR image is reconstructed using a 
homogenous mesh as there was no indication of a target on US. Figure 33(d) to (f) 
correspond to target being embedded at different longitudinal locations at slightly 
different depths. The embedded object is clearly visible in the US images as anechoic 
shadows. The NIR imaging without a priori information can clearly recover the object, 
but with inconsistent and potentially much under-estimated absorption coefficients. When 
the target location and size information are used to guide the NIR image reconstruction, 







Figure 33 Avian tissue imaging with embedded solid target 
(a) front view; (b) top view; (c) no inclusion; (d) inclusion is at 20mm; (e) 
35mm; (f) 58mm, longitudinally, respectively. 
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4.7 Internal imaging of avian tissues 
 
Figure 34 Internal imaging of avian tissue embedded with a piece of liver 
 
As shown in Fig. 34(a) the empty abdomen of a whole chicken was filled with 
chicken breast tissue and a piece of chicken liver was embedded within the breast tissue. 
The embedded liver shows up as the hypo-echoic region circled in Fig. 34(b). The NIR 
image reconstructed without any target information is given in Fig. 34(c), in which the 
absorptive mass does correlate longitudinally with the liver tissue. Fig. 34(d) shows NIR 
image reconstructed by treating the liver mass as a sphere. Fig. 34(e) shows the NIR 
image reconstructed by excluding the non-tissue region from the background of Fig. 
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34(e). Fig. 34(f) shows the NIR image reconstructed by taking into account the irregular 
shape of the liver mass. Among the 3 spatial prior implementations, the one in Fig. 34(f) 
is the most accurate wherein the absorption coefficient of the chicken liver mass is also 
the closest to the realistic value 
[104]
. 
4.8 TRUS-coupled trans-rectal NIR tomography of canine prostate in situ 
TRUS-coupled trans-rectal NIR imaging of the prostate is conducted on a canine 
cadaver. The prostate was exposed and approximately 0.33ml of homogenized foal liver 
was injected ventral-dorsally, para-median in the left lobe of the prostate. The prostate 
was then enclosed in thick layers of peri-prostate tissues. On the TRUS image of Fig. 
35(a) the injected liver tissue is visible by the mass proximal to the center of the prostate 
and the vertical hyper-echoic strip at the ventral side of the prostate. The large hypo-
echoic region at the upper half was due to air. The mesh generated in Fig. 35(b) has 
excluded the air based on the US image. The rectum wall was not outlined in the mesh 
because of its close proximity and near opposition to the US transducer due to the small 
size of this canine cadaver. The rectum layer may be included when imaging a larger 
subject. The finalized mesh given in Fig. 35(b) shows nested-domains where there is a 
relatively small prostate and a much smaller target in the prostate. The NIR image in Fig. 
35(c) is reconstructed by applying the 3-step hierarchical reconstruction method 
introduced in the previous paper. A highly absorptive mass is clearly recovered out of the 
injected liver tissue. The absorption coefficient of the foal liver tissue in Fig. 35(c) is 
lower than that of the avian liver tissue in Fig. 35(f); nevertheless both values are at the 
order of 0.1mm
-1
, indicating high absorption by both tissues. The reconstructed 
absorption coefficients of the prostate and the peripheral tissue are given in Table 9. It is 
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Figure 35 Trans-rectal NIR / US imaging of canine prostate in situ 
 
Table 9 Reconstructed absorption value of ex vivo canine prostate 
Region Background Prostate Injected  liver 
Reconstructed value (mm
-1
) 0.0062 0.0309 0.1301 
 
4.9 Trans-rectal NIR tomography of target ambiguous to TRUS 
In all the tests presented in previous work, the target of interest is visible or at 
least sensitive to US, therefore US spatial information of the target is readily rendered to 
guide the NIR image reconstruction. If the target is ambiguous to US, it may still be 
recognizable by NIR-only reconstruction. One example is given in Fig. 36 wherein a 
piece of chicken breast tissue was dyed with diluted India ink (Pelikan Schwarz – black) 
and then placed in the middle of the natural chicken breast tissue. The approximate 
boundary of the dyed tissue is marked with the dash-circle in the US image. This 
embedded tissue is hardly distinguishable in the TRUS image; therefore the NIR image 
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reconstruction was performed without any a priori information. The target is identified 
by NIR even though the depth and size were not accurate. This result may show positive 
indication on the clinical application of trans-rectal NIR/US measurement providing the 
fact that up to 40% of prostate tumors are not sensitive to US. Besides using NIR 
information to characterize US-sensitive lesions, if the NIR imaging is able to discover a 
lesion that is otherwise non-suspicious on US, the overall sensitivity and specificity of 
TRUS-based prostate imaging may be improved 
[66][91]  
 








IN-VIVO OPTICAL IMAGING OF CANINE PROSTATE 
 
Dog has been previously used for prostate tumor model studies because of the 
morphological and functional similarities between canine and human prostate glands. The 
studies were conducted in Center for Veterinary Health Sciences at Oklahoma State 
University under a protocol approved by the university's Institutional Animal Care and 
Use Committee. It was also inspected on site by DOD. Three dogs have been used for the 
prostate tumor model study up to the completion of this thesis. The first one is 4 years of 
age dog, 20 kg sexually intact, adult mixed-breed, but the injected tumor failed to grow in 
its prostate. The second one is a 12 kg sexually intact adult purpose-bred Beagle dog 
which successfully grew a transmissible venereal tumor (TVT). This dog was measured 
by single wavelength optical system at 840nm which gave associated high contrast of 
optical absorption and optical scattering. The third one is an adult 20-kg, intact male, 
foxhound estimated to be six years of age. It also had TVT grown in its prostate and was 
measured by dual-band optical system at 785nm and 830nm that could provide the 
contrast of total hemoglobin concentration [HbT]. The physical examination and 
ultrasound revealed normal prostate for these dogs before the injection of the 
transmissible venereal tumor (TVT) cells. 
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5.1 Canine prostate imaging geometry 
As shown in Fig. 37, the dog was anaesthetized during the experiment. The 
rectum was cleaned and filled with ultrasound gel. The combined TRUS/NIR probe was 
covered by condom and inserted through the rectum to imaging the prostate. In the 
experiment, the probe was handled by experienced veterinarians and those different 
positions were monitored by the real-time TRUS. 
 
Figure 37 Canine prostate 
 
Figure 38 shows the axial and sagittal ultrasound of the canine prostate. In the 
clinical axial plane imaging, the left side of the image actually indicates the prostate right 
lobe, the right side of the image shows the left lobe of prostate as well. The prostate 
region can be well defined by the capsule line shown in the ultrasound image. In the 
sagittal plane image, the bladder and pelvic bones can also be used to correlate the 
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location of the prostate with respect to the probe since the bladder has a clear hypo-
echoic region and the pelvic bone has a distinct hyper-echoic region in US images. 
 
Figure 38 TRUS images of prostate at axial and sagittal plane 
 
In each experiment, the probe was put into five different angles with respect to the 
prostate in order to imaging five different parts of prostate from right lobe edge to left 
lobe edge as shown in Fig. 39 which were labeled as ―Right lobe edge‖, ―Right lobe 
middle‖, ―Middle line‖, ―Left lobe middle‖ and ―Left lobe edge‖. 
 
Figure 39 Five sagittal planes for in-vivo of canine prostate 
 
At each sagittal imaging plane, the probe was put into three different longitudinal 




Figure 40 Three longitudinal locations for in-vivo imaging of canine prostate 
5.2 Canine Transmissible Venereal Tumor (TVT) 
The unique canine TVT is a round cell tumor that mainly affects the external 
genitalia and can be transmitted from animal to animal during copulation, regardless of 
histocompatibility. TVT cells can be propagated in immunocompromised (SCID) mice 
and transferred to different tissues of the dog to result in a neoplastic mass effect useful 
for imaging studies (Fig. 41) 
[105]
. 
             
   (a) Liver       (b) Lung         (c) Muscle 
Figure 41 cTVT grown on different tissue of canine 
 
As shown in Fig. 42, compared with the normal prostate tissue, the TVT tumor 
has a distinct boundary from its higher cell density, and the TVT cells has fewer 
chromosomes than normal cells. The photomicrography of TVT cells also showed that it 
has a large hyperchromatic nucleus and single conspicuous nucleolus which could 
introduce a higher optical absorption and scattering. 
74 
 
                   
Figure 42 Photomicrography of cTVT in prostate 
 
In this project, the TVT cell line was obtained cryopreserved from MD Anderson 
Cancer Center (Houston, TX). Following two cycles of inoculation into the subcutis of 
non-obese-diabetic/severe-combined-immunodeficiency (NOD/SCID) mice, neoplastic 
cells were recovered and homogenized for injection into the canine prostate gland. Fig. 
43 showed a TRUS monitored injection. Approximately 3 cc of TVT cells were 
aseptically injected transperineally into the right lobe of the prostate using a 6-inch 16 
gauge hypodermic needle under TRUS visualization. 
 
Figure 43 TRUS monitored the TVT injection 
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5.3 Imaging of normal canine prostate 
Figure 44 gives three sets of sagittal TRUS/NIR imaging of the normal canine 
prostate at right lobe, middle-line and left lobe. The dimension of NIR image is the same 
as the TRUS with 50mm (cranial to caudal) × 30mm (dorsal to ventral). In each column, 
the absorption, scattering and effective attenuation coefficients are reconstructed from 




Figure 44 NIR images of normal canine prostate 
 
The NIR absorption coefficient images are displayed at a color-scale of [0.007 
0.014] mm
-1
. The NIR transport scattering coefficient images are displayed at a color-
scale of [3.000 6.000] mm
-1
. The NIR effective attenuation coefficient can be calculated 
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by previous Equ. 36 From the experiments, the calculated µeff of normal canine prostate is 
in the range of [0.250 0.500] mm
-1
. The color-scales in all images represent a background 
threshold at half of the maximum value of the color-scale. At this scale, the locations of 
the NIR regions indicated the prostate had excellent position correlation with prostatic 
images obtained using TRUS. The urinary bladder is shown as an anechoic structure on 
TRUS, which is similar to images using NIR. Most of the peri-rectal tissues are also not 
identified using NIR except at the periphery of the urinary bladder. The prostate is 
consistently demonstrated in NIR images as having positive-contrast with respect to the 
peri-prostatic tissues, with an average of more than 2-folds of contrast in absorption, 
reduced scattering, and effective attenuation. In addition, the prostate is more optically 
heterogeneous in the middle-line and more optically attenuating toward the internal 
aspects of the prostate than in the peripheral aspects of the gland. 
5.4 Single wavelength NIR imaging of canine prostate with TVT 
The TVT model was successfully cultivated on the second dog. The injection 
procedure was the same as previous description in Section 5.2 and shown in Fig. 45 (a). 
During retraction of the injection needle, it was assumed that TVT cells could leak from 





(a) TVT injection of Buck 
 
 
(b) TVT growth ~2 weeks after injection 
 
(c) TVT growth ~6 weeks after injection 
Figure 45 TVT growth from injection to 6 weeks 
78 
 
In Fig. 45(b), after about 2 weeks, the injected TVT cells grew up both inside of 
prostate and along the needle track. Some leaked TVT cells started to grow outside of 
prostate. When 5~6 week passed, in Fig. 45 (c), the inside prostate TVT tumor grew 
bigger that it crossed the middle line and extended to the left lobe. The outside TVT 
tumor also became large enough to cover the entire right lobe. All those tumors sketched 




Figure 46 Monitoring of optical absorption and reduced scattering at right 
lobe, middle-line and left lobe of prostate before the injection, 14 days 
after injection and 35 days after injection. 
 
Figure 46 presents the trans-rectal NIR and TRUS images acquired at the middle 
of the right lobe, the middle-line of the prostate, and the middle of the left lobe, which 
were obtained before the TVT injection, 2 weeks after the TVT injection (when US and 
rectal examination showed no evidence of tumor growth), and 5 weeks after the TVT 
injection (when the tumor growth was evident on both US and rectal examination). The 
absorption (a) and reduced scattering (b) images correlate to the same set of US. The 
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image dimensions are all 60mm30mm (cranial-caudaldorsal-ventral). On the 5
th
 week 
TRUS images of the right lobe and middle-line, corresponding to Fig. 46, the hypo-
echoic region L1 indicated an intra-prostatic mass; the large hypo-echoic region L2 
indicated a mass ventral and caudal to the prostate that could have connection with L1; 
the NT on the right lobe denoted the needle trajectory for introducing the TVT cells with 
longitudinal hypo-echoic regions including L3 seen along the NT. On the 5
th
 week NIR 
image of the right lobe the hyper-absorptive regions corresponded longitudinally to L1, 
L2, and L3. The 5
th
 week NIR image of the middle line displayed less and smaller hyper-
absorptive masses indicative of L1, L2, and L3. Trans-rectal NIR/US images performed 
at the left lobe were shown with no abnormal features on US and no hyper-absorptive 
regions on NIR. At the 2
nd
 week NIR absorption images, hyper-absorptive regions were 
found intra-prostatically in the right lobe only (L1) and dorsal to the pelvic bone in the 
right (L2) with potential extension to the middle line. The longitudinal locations of these 
hyper-absorptive regions correlated very well with those of the hypo-echoic and hyper-
absorptive regions found in the 5
th
 week. It should be noted that the NIR array surface is 
3mm ventral to the TRUS surface, therefore the nodules were shown slightly dorsal on 
NIR than on US. The progression of the dimensions and contrasts of the hyper-absorptive 
regions from the 2
nd
 week to the 5
th
 week implied tumor growing in right lobe and 
extending toward the middle-line. It is observed that the growth of the tumor was 
indicated earlier by the NIR absorption images than by the TRUS, and combining the 
information of NIR and TRUS led to earlier and more accurate findings of the tumor 
growth than did with TRUS alone. 
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The hyper-absorptive masses in Fig. 46(a) were shown in Fig. 46(b) with different 
patterns of the reduced scattering contrast. On (b) the L3 had much higher contrast than 
did the other masses corresponding to L1 and L2. The growth of the tumors L1 and L2 at 
the 2
nd
 week on (b) are not as evident as on (a). 
The progressions of the peak NIR absorption and reduced scattering contrasts 
within the rectangular region corresponding to L1 as outlined in Fig. 46, with respect to 
the background values for normal peri-rectal parenchyma, are given in Fig. 47. The clear 
trend of contrast increase is believed as the demonstration of imaging the tumor growth 
since NIR tomography is a non-linear process in which the enlargement of target may be 
reconstructed as enhanced contrast in addition to volume changes when reconstructing 
without the target spatial prior.  
 
Figure 47 Estimated contrast increase in 5 weeks 
 
Figure 48 displays the sagittal NIR/US images obtained by displacing the probe at 
3 longitudinal locations along the middle plane of the right lobe from the cranial side to 
caudal side. At location 1, the L1, L2 and L3 (referred to Fig. 46) were all within the US 
field of view, while at location 2 the L3 was moved out of the US view. At location 3 
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only L1 was shown on US. The overall information of hyper-contrast masses on trans-
rectal NIR images correlated well with the US hypo-echoic regions. 
 
Figure 48 The fifth week imaging of prostate at right lobe 
 
Figure 49 gave a retrospective view of the reduced optical scattering monitored in 
6 weeks from the baseline taken right before the TVT injection. For the optical 
absorption images, at the second week, the hyper-absorption regions were found 
intraprostatically in the right lobe and dorsal to the pelvic bone. The contrast became 
significant when 5 weeks passed indicating a malignant tumor growth. The contrast of 
reduced scattering image during the first two weeks was not as high as absorption 
contrast, an increased contrast in scattering could still be concluded along the TVT tumor 




  (a) absorption image     (b) reduced scattering image 
Figure 49 Retrospective view of right lobe monitoring in 6 weeks 
 
NIR optical tomography reconstruction used a 3-D mesh; Fig. 50 displays the 
three sagittal TRUS images taken at the mid-line of the prostate, the middle portion of the 
right lobe of the prostate, and the right lateral edge of the prostate. As shown in Fig. 46, 
the small hypo-echoic region L1 indicates an abnormal intra-prostatic mass. The large 
hypo-echoic region L2 indicates an abnormal mass anterior and caudal to the prostate that 
may have connection with L1. The NT on the right lobe US image denotes the needle 
trajectory for introducing the TVT cells. Longitudinal hypo-echoic regions including L3 
are seen along the NT. The three sagittal NIR images correspond to the US taken at the 
middle portion of the right lobe, 10mm medial to it and 10mm lateral to it, respectively. 
Hyper-absorptive regions on sagittal NIR images correspond to L1, L2, and L3 on 
sagittal US images. The 10mm-medial NIR image shows reduced contrast for the 
absorptive masses, and the 10mm-lateral NIR reveals connected strong absorptive 
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masses. The bladder is seen as slightly hypo-echoic at the 2 more medial sagittal US 
images; however, no hyper-absorptive mass is presented at the left-most region of the 
sagittal NIR images.  
The three axial TRUS images were taken at the cranial edge of the prostate 
crossing L1, the caudal edge of the prostate crossing L2, and the peri-rectal region 
crossing L3. The axial US images show a small hypo-echoic intra-prostatic mass at 
cranial side of the prostate, the bulging of the right lobe and extending of the L2 over the 
prostate mid-line that correlates with the findings on mid-line sagittal US, and large peri-
rectal hypo-echoic mass cranial to the perineum. Of the five axial NIR images, the 
longitudinal positions are 10mm apart from cranial to caudal. The axial NIR image A2 
should contain L1, and the axial NIR image A5 should contain L3.  
The coronal NIR images correspond to 5mm, 10mm, and 15mm anterior to the 
anterior edge of the rectal lumen.  The hyper-absorptive mass indicative of L1 is seen 
medial to the hyper-absorptive masses indicative of L2 and L3. The anatomies of the 
hyper-absorptive masses on the NIR images in 3-views agree with the hypo-echoic 
regions on the US images in 2-views.  
The US and NIR imaging were also performed at the middle-line of the left lobe 
where no abnormal features were found on the US, and globally homogenous and low 




Figure 50 3-D absorption images of prostate at 5th week 
 
With the same data set, the reconstructed reduced scattering optical image was 
displayed in axial, sagittal and coronal plane accordingly to Fig. 50. The indications of 
masses corresponding to L1, L2 and L3 are not as profound as in absorption images, 
although L3 seems much higher contrast than L1 and L2 masses. The scattering contrast 




Figure 51 3-D reduced scattering images of prostate at 5th week 
 
The gross and histological findings (obtained 8-week post-injection) illustrated in 
Fig. 52 confirmed intra- and peri-prostatic neoplastic infiltrates with masses also located 
along the urethra and peri-rectal tissue; the latter related to dissemination along the 
needle track during TVT inoculation. All masses consist of diffuse sheets of a 
monomorphic population of neoplastic round cells dissecting through pre-existing 
fibrovascular stroma. The neoplastic cells have large hyperchromatic nuclei, single 
conspicuous nucleoli and moderate amounts of featureless cytoplasm. The cytological 




Figure 52 Pathology finding of prostate TVT 
 
The single wavelength NIR optical tomography of prostate imaging results 
indicated that the combining the information of the optical and ultrasound images could 
get the chance to find the prostate tumor at its early stage. However it must be noted that 
the optical reconstruction without a priori suffers from the detection sensitivity as 
discussed in section 4.2. The suspicious regions at around 15mm away to the probe will 
be reconstructed more accurately than other deep regions or the regions far away from the 
middle sagittal plane. To apply the anatomic a priori information in the optical 







Dual band Trans-rectal US/NIR imaging system 
 
In near-infrared (NIR) band the light interacts with tissue at microscopic level, largely by 
two mechanisms: one is the strong scattering by subcellualr organelles, the other is the 
dominant absorption by chromophores such as hemoglobin molecules. The utility of non-
invasive imaging of the tissue oxygenation by multi-band near-infrared (NIR) light has 
been recognized for decades. The distinctly different spectra of hemoglobin absorption 
(Fig. 53) of the NIR light when being oxygenated and deoxygenated have enabled finding 
lesions of angiogenesis or altered oxygenation indicating malignant changes. It has been 
well recognized in breast imaging that the increased level of hemoglobin concentration in 
the micro-vasculature of breast cancer causes an elevation of NIR absorption and 
alteration of NIR scattering. For a sonographically-suspicious lesion in breast, including 
the information of total hemoglobin concentration [HbT] in the lesion measured by NIR 






Figure 53 Extinction coefficient of Hb, HbO and water 
 
These findings suggest that augmenting TRUS with NIR measurement of [HbT] 
in prostate likely will improve the accuracy of detecting prostate cancer. Strong 
pathological evidences have suggested that the vascular supply to malignant prostate 
tissue differs from the vascular anatomy of normal prostate tissue. Other studies on 
prostate cancer have found a correlation between the cancer and increased micro-vessel 
density. All those studies have demonstrated a clear association of increased microvessel 
density with the presence of cancer. Several studies on Doppler Ultrasound prostate 
imaging found it is able to detect signal from small vessels such as those feeding vessels 
to the microveascular bed, but due to its sensitivity dependence upon motion, it does not 
detect signals from the microcirculation itself 
[109]~[113]
. 
Changes of the local oxygen saturation were also observed during the prostate 
photodynamic therapy under interstitial NIR measurement. Tissue oxygenation status is 
also an important prognostic indicator for androgen-deprivation therapy of newly 
diagnosed metastatic prostate cancer. These increasing evidences indicate that the ability 
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of quantifying the hemoglobin concentration and oxygen saturation in prostate is 
important for the diagnosis, prognosis, and treatment monitoring 
[114]~[117]
. 
From previous chapter V, it has been demonstrated that combining trans-rectal 
NIR absorption measurement of the prostatic tissue at 840nm and the ultrasonography 
detected the development of a transmissible venereal tumor (TVT) in canine prostate at 
least a week earlier than by using TRUS alone. The much denser cellular morphology of 
TVT was related partially to the NIR absorption change seen in that study, but the 
association of [HbT] with that change was not quantified due to the use of single-band 
NIR measurement. In previous single wavelength system, the NIR imager 
superluminescent diode light source with ~14nm bandwidth @ 840nm is used to excite 
all source channels. The bandwidth would certainly introduce wavelength-dependent 
attenuation among source channels for those tissue chromophores. The reconstructed 
absorption coefficient is therefore a value averaged over the band coupled into the source 
channels. Luckily the absorption of the tissue chromorphores like hemoglobin is less 
wavelength-dependent in the close vicinity of 840nm. If the source coupling method is 
performed at an additional wavelength, such as 780nm, to quantify the oxygen saturation, 
it may be necessary to compensate the wavelength-dependent absorptions among source 
channels in image reconstruction. 
Encouraged by the applications of multi-band NIR light in breast cancer imaging, 
researchers recently start to develop NIR tomography techniques for trans-rectal imaging 
of the prostate. In this chapter, the trans-rectal NIR absorption measurement is performed 
spectrally at 785nm and 830nm that is necessary to extracting the [HbT] of prostatic 
tissue. This study demonstrates that combining trans-rectal NIR measurement of the 
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prostatic [HbT] and the ultrasonography likely will detect the lateral involvement and 
predict the longitudinal development of TVT in canine prostate earlier and collectively 
more accurate than by using TRUS alone 
[63]
. 
Initially, before applying two-wavelength light on the trans-rectal NIR 
tomography system combined with TRUS. It was first applied to a 20mm (Diameter) 
axial imaging probe at 785nm and 850nm for testing. 
6.1 Dual-band trans-rectal axial imaging applicator 
Figure 54 illustrates the configuration of the 20mm axial-imaging endo-rectal NIR 
probe. There are 8 source and 8 detector optical channels spaced circularly. Each optical 
channel was constructed with a 1.0mm core diameter fiber and aligned to a 45º rod lens 
of 2mm diameter to deflect the beam transversely for side-firing. A 2mm drum lens was 
attached for illumination and beam focusing. The length of the probe is 7‖ which was 




Figure 54. Diagram of 20mm endoscope NIR tomography axial imaging probe 
 
This 20mm diameter probe was connected to a time-multiplexing light delivery 
setup for dual-band NIR tomography as shown in Fig. 55. The ~100mW outputs from 
two laser diodes (LDs) at 785nm and 850nm were coupled by a bifurcated fiber to a fiber 
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switch that was home-made using a linear motorized translation stage (Zaber 
Technologies) which was basically the same as the single wavelength source switching 
set up described in section 3.3. The switching of the light upon 8 source channels was 
synchronized with the CCD acquisition of all those corresponding 8 source signals 
having been received by all detectors. 
 
Figure 55 Dual wavelength NIR tomography system for 20mm-probe 
 
Each complete set of the data consists of 8 frames corresponding to each source 
channel being turned on by the fiber switch. Fig. 56 is the one frame data when the 
source 3 is switched on. Because of the longer distance between the source and detector, 
the total 64 data sets follow a better linear fitting curve than the data sets for previous 
studies on a 13mm probe. The use of fiber switching also minimized the cross-talk 
among the adjacent source channels. However, the weakest signal may submerge in the 




Figure 56 CCD image and raw data of 20mm probe 
 
In the previous measurement by use of the 13mm probe, the 2.5mm separation of 
the target from the probe surface was too small to be differentiated by the NIR 
tomography. This is not only related to the relatively low resolution of the NIR 
tomography, but also to the non-uniform sensitivity of the axial imaging probe along the 
radial depth as well as the use of continuous-wave measurement that does not give 
reliable information of the photon path-length. Further test on the 20mm axial-imaging 
probe confirmed that the depth of a target is severely compromised at this axial-imaging 
geometry, as indicated in Fig. 57. A solid cylinder shape phantom (10mm in diameter and 
16mm in length) was put into a homogeneous background of 1% solution intralipid. The 
phantom was put 10mm away (center) from the 20mm probe surface. The solid phantom 
has the optical coefficients of a = 0.0064mm
-1
, s = 0.91mm
-1
. The high absorption 
regions reconstructed at two wavelengths are consistent, but at a position close to the 
probe surface. Improving the depth localization of the axial-imaging NIR tomography 
may be rendered by incorporating spatial information of the target. Yet, the curvature of 




Figure 57 Stand-alone optical reconstruction of transverse images 
 
After the initial validation of the dual-band system on the axial imaging probe, the 
system was applied on the trans-rectal sagittal imaging probe. 
6.2 Dual-band trans-rectal sagittal imaging system 
The upgraded TRUS/NIR system for dual-band trans-rectal mode imaging is 
shown schematically in Fig. 58 and photographed in Fig. 59. Two-wavelength light at 
830nm and 785nm were coupled in the source channel by a bifurcated fiber delivered to 
the switching source coupling system. The 7 NIR detector channels are coupled to a 
spectrograph of 300mm focal-length and 300 lines/mm grating, which separated the 7-
channel dual-band light onto an intensified CCD camera with  12mm12mm chip size 




Figure 58 Dual-band optical imaging system 
 
The Laser diodes were mounted in the temperature controlled laser diode mounts 
(TCLDM) from Thorlabs, both of which were connected to two laser diode controller 
(LDC-3722B ILX Light wave Inc.). The TCLDM9 uses two thermo-electric coolers 
(TEC) to precisely regulate the operating temperature of a laser diode. Each TEC element 
is capable of up 10W of cooling at a maximum operating current of 5 Amps. The two 
TECs are connected in series so that a single connection provides up to 20W of cooling. 
Temperature sensing is done by one of two ways. An AD592 Temperature Transducer 
provides a linear temperature monitor proportional to the laser temperature in degrees 
Celsius. A 10kΩ NTC thermistor is also provided for controllers that only work with 
thermistor feedback. It also has a 50Ω RF input using a bias-tee allows the laser to be 




Figure 59 Photography of multi-band optical imaging system 
 
Figure 60 Temperature controlled laser diode mount 
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Two cables of the laser diode driver and temperature controller have to be home-
made because that the pin-definitions of LDC-3722B are different from TCLDM9. The 
connection of LDC-3722B and TCLDM9 was shown in Appedices2. 
 
Figure 61 Front panel of laser diode controller 
 
One set image in the test of those two wavelength separated by spectrometer is 
given in Fig. 62. Both of the acquired two wavelength data sets were calibrated by the 
linear model based on the semi-infinite boundary condition described in section 4.1. 
 




The dual-band measurements of absorption on sagittal-plane are reconstructed by 
optical stand-alone reconstruction in Fig. 63.  
           
   (a) 785nm             (b) 830nm 
Figure 63 Stand-alone optical imaging of dual-band system 
 




) was put in the 
middle-sagittal plane of the probe at a depth of 10mm and 15mm, respectively, in a 
homogeneous background (1% solution intralipid). Both targets appear approximately at 
the same depth of 10mm by NIR optical stand-alone reconstruction corresponding to the 
depth sensitivity of the probe discussed in previous section 4.3. Again, the absorption 
value of the target is underestimated because of the stand-alone optical reconstruction. 
Fig. 64 gives the dual-band reconstruction after incorporating the spatial information of 
the target available from the TRUS. The target spatial information is used to develop a 
mesh representing a target at the correct location and the background. The prior-guided 
NIR reconstruction at both wavelengths gives more accurate recovery of the absorption 






Figure 64 prior-guided reconstruction incorporated in dual-band imaging system 
 
6.3 Calibration of dual-band optical system 
From the discussion in section 2.1, different chromphores concentration can be 
calculated from the optical absorption value. In this dual-band optical system, the 
absorption coefficients at 785nm ( 1a ) and 830nm (
2a ) are reconstructed first, then 



























           Equation 43 
where 
e  denotes the molar absorption coefficient as shown in section2.1. 
Summation of these two concentration values leads to the total hemoglobin: 
[HbT]=[HbO]+[Hb]            Equation 44 
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And the oxygen saturation is defined as the ratio of the oxygenized hemoglobin to 




StO 2             Equation 45 
The initial system calibration test set up was built as described in Fig. 65. A 
similar blood circulation system was built for a 13mm axial imaging probe test. It was 
demonstrated that the blood oxygen changes can be obtained by a dual-band endo-rectal 
optical measurement. In Fig. 65, Oxygen and Nitrogen gas tanks were introduced to the 
fresh bovine blood (300mL) in a tank to administer the level of blood oxygen saturation 
(StO2) which was monitored by an oxi-meter. A pump delivered the blood from the tank 
to a cylindrical container (40mm in length with 20mm in diameter) placed 15mm away 
from the endo-rectal NIR probe (center to the probe surface). The cylindrical container 
for imaging was made by the solid phantom material used in the system calibration to 
reduce the photon reflection on the interface of the container and the intralipid. The wall 
of the container is fabricated as thin as possible (<0.5mm) to minimize the attenuation 







Figure 65 Set up of blood oxygen test 
 
In order to quantify the system performance of the dual-wavelength system, the 
absorptions in dual-wavelength were reconstructed with a priori information from US 
image. Then by using the Equ. 42~45. the StO2 in the blood can be calculated. Fig. 66 
gives the reconstructed blood oxygen concentration with respect to the measurements 
from the Oxi-meter. The increased oxygen saturation was recovered. 
 
Figure 66 Experimental results of increased StO2 
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The [HbT] measurement was calibrated using different concentrations of fresh 
bovine blood, whose optical absorption spectra in 780-840nm are considerably close to 
that of human blood. The bovine blood was held in a cylindrical container fabricated out 
of a tissue-mimicking material, which was placed in bulk 1% intralipid solution with 
optical properties similar to typical soft tissue. 
 
Figure 67 [HbT] calibration with bovine blood in 1% Intralipid 
 
The [HbT] measurements were performed at different locations and distances of 
the blood-container with respect to the NIR applicator. On average a linear relationship 
was established between the measured and set values of [HbT], above a residual point as 
is shown in Fig. 67. Another calibration of StO2 was performed with a sodium dithionite 
(Na2O4S2). Dithionite induces dissociation of dioxygen by the reduction of the external 
dioxygen and not by diffusion into the cell. So the structure and function of the cell 
membrane remains relatively unchanged. In the experiments, the blood was divided into 
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several 10g samples. Sodium dithionite was added by 5mg, 10mg, 15mg and 20mg 
accordingly. Since sodium dithionite did not change [HbT], Fig. 68(a) gave a pretty 
stable line for both reconstructions with or without a priori. The reconstructed [HbT] 




                                 (a) [HbT]                                    (b) StO2 
Figure 68 Calibration with bovine blood added by sodium dithionite 
 
The reconstructed StO2 was shown in Figure 6.15 (b). The decreasing trend of the 
StO2 was recovered but the accuracy of the StO2 for both reconstruction with or without 
a priori were still quite different from the expected value. Each error-bar calculated in the 
figure has five data sets, the a priori reconstruction gives a better consistent results than 
the stand-alone optical reconstruction. Some previous studies addressed that the 
combination of 785nm and 830nm was good for [HbT] reconstruction, but for StO2, the 





Figure 69 Comparison of [HbT] reconstruction with and without prior 
 
As previous discussion in section 3.2, the depth sensitivity problem still exists in 
the dual-band optical reconstruction. Fig. 69 gives a comparison of reconstructions at 
different depth with and without prior. The target in the experiment was a cylinder shape 
as described in section 3.1 and was put at the middle of the probe with different depth 
from 15mm to 25mm. The background is a 0.2% intralipid added with ink that had 
absorption of 0.0125mm
-1
 and a reduced scattering around 0.2mm
-1
. The blood sample 
was diluted by saline water to a 10% solution. Both of the reconstructed absorption 
values are close to the true value. However, with the depth increased the reconstructed 
value without a priori decreases dramatically when the target depth is more than 15mm 
away to the probe. For reconstruction with a prior, it starts to decrease when the imaging 
depth is over than 25mm. 
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6.4 In-vivo dual-band TRUS/NIR imaging of canine prostate with TVT 
The dual-band in-vivo canine prostate study was approved by the Institutional 
Animal Care and Use Committee of Oklahoma State University. The canine protocol was 
also inspected on-site by the U.S. Army Medical Research and Material Command. As 
described at the beginning of chapter 5. The third dog ―Buck‖ was an adult 20-kg, intact 
male, foxhound estimated to be six years of age was used. Three week baseline images 
before the TVT cell injection were taken as comparison to the post-injection images. 
Under general anesthesia, ~3 cc of TVT cells were aseptically injected transperineally 
into the right lobe of the prostate using a 6-in. 16-gauge hypodermic needle, via US 
visualization using an Aloka UST-9132I convex array multi-frequency (3.75-10 MHz) 
finger-grip  transducer. The TVT cells were confined within the right prostatic lobe 
during the injection in two locations, one near the cranial aspect, and the second slightly 
caudal to the mid-point of the right lobe as the needle was withdrawn. The dog then 
underwent monitoring, including digitally palpated trans-rectal examination, trans-rectal 
US and trans-rectal optical tomography, at 7, 14, 21, 31, 38, and 45 days post-injection. 




Figure 70 Injection of the TVT cells for Buck, the 3
rd
 canine subject 
 
The base-line US indicated that the prostate measured 6cm from cranial to caudal. 
It also revealed a cluster of prostatic cysts resembling a ―face‖ in the right aspect of the 
gland. This ―face‖ landmark, the location of which is shown in Fig. 70(c), facilitated 
multiple images taken in the same relative areas in that location over time throughout the 
course of the imaging study. Transrectal optical tomography was performed on five 
quasi-sagittal planes across the prostate, including the middle-sagittal plane, half-way to 
the right lateral edge, the right lateral edge, half-way to the left lateral edge, and the left 
lateral edge, of the prostate gland as shown in Fig. 70(d). On each of the five quasi-
sagittal planes, the imaging was performed at three different longitudinal positions of the 





Figure 71 TRUS/NIR images of 5 sagittal planes at 7 days after injection 
 
Among the US/NIR images, only the representative sets corresponding to 7-days 
and 31-days post-injection were presented in Fig. 71 and Fig. 72. Each group of images 
for the 7-days and 31-days were taken at two positions, as indicated by the ~25mm shift 
of the ―face‖ landmark. On US, the ―face‖ landmark was clearly visible by 7-days but 
distorted significantly by 31-days. The 7-days image revealed a region with higher [HbT] 
in NIR images and hypo-echoic, near the cranial injection site in the right lobe. That 
region-of-interest disappeared in images taken 14-days and after, therefore it were 





Figure 72 TRUS/NIR images of 5 sagittal planes at 31 days after injection 
 
The US images at 31-days post injection revealed a cluster of hypoechoic masses 
with irregular-boundaries in the caudal aspect of both right and left lobes and overall 
greater volume of the hypoechoic masses in the left lobe than in the right lobe. The 
spatial content of the NIR hyper-[HbT] regions generally agree with that of the US hypo-
echoic regions in the caudal-to-middle-left aspect of the gland, but presented a different 
pattern in the cranial-to-right aspect of the gland. The US presented a large hetero-echoic 
mass dorsal-cranial to the pelvic bone and extending predominantly to the left lobe but 
also having right-lobe involvement. Near that location the corresponding NIR image 
revealed a cluster of hyper-[HbT] region, but the center of which seemed displaced 
slightly cranially with respect to that of US hypo-echoic mass. Retrospectively in the 7-
days NIR images a smaller but stronger hyper-[HbT] region was found near that location. 
Also in the 7-days US images a substantially smaller hypoechoic region was weakly 
distinguishable near that location. The location of the hyper-[HbT] region also displaced 
slightly cranially with respect to that of the marked US hypoechoic mass in 7-days 
images as well. This hypoechoic mass, developing much more rapidly than other masses, 
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presented marked enhancement of periphery blood flow when imaged by Doppler US at 
38-days post-injection. 
 
Figure 73 TRUS/NIR images over 4 weeks in right lobe 
 
Figure 73 illustrates the changes of [HbT] of the prostate right lobe middle-
sagittal plane from baseline to 45-days post-injection. In a marked 10mm-diameter 
region, which correlated to the US hypo-echoic mass grown caudal to the prostate. The 
average [HbT] in that region changed from 120 M to 375 M, nearly 300% change over 
the 45-days of development (shown in Fig. 74). The [HbT] values obtained in this study 
agree with the range indicated by other works by time-resolved measurement as shown in 




















Figure 75 TRUS/NIR images over 4 weeks in left lobe 
 
Another sets of TRUS/NIR images of left lobe prostate from week 0 to week4 are 
shown in Fig. 75. Since the injection was at the right lobe, at week1, there was no similar 
high contrast pattern as right lobe in Fig. 76. However, the leaked TVT cells started to 
grow in the left lobe in early weeks which was observed at week 1 and week2. In week 4, 
the tumor mass became big volume at caudal to prostate. 
 




Figure 77 Dog3 week7 at right lobe 
 
Figure 76 and 77 showed the right lobe prostate TRUS/NIR images at the middle-
sagittal plane after 6 weeks and 7 weeks post-injection. The images were acquired at 
those three different longitudinal locations from the cranial to prostate, middle of the 
prostate to the caudal of the prostate. The hyper-contrast region of [HbT] correlated with 
the hypo-echoic region in TRUS images indicating the tumor mass. 
 
Figure 78 The 7 slices of the prostate gland were sectioned from cranial to 




The excised prostate (Fig 78) was approximately 10cm5cm5cm in size. The 
prostate was step-sectioned into approximately 1.5cm slices. The gross examination 
confirmed multiple coalescing foci of TVT in the caudal aspect of the gland, and 
significant infiltration of the tumor from the right to the left lobe. 
The dog was humanely euthanized using a barbiturate overdose at 55-days post-
inoculation followed by thorough gross inspection and excision of the prostate gland and 
urinary bladder. The prostate was serially sectioned by freehand technique in transverse 
planes. These planes were thought orthogonal to the quasi-sagittal planes used for 
transrectal US-coupled optical tomography. Routine histology with hematoxylin and 
eosin stain for light microscopy was performed on specimens selectively sampled from 
the sectioned prostate, each of which contained tissues that were grossly expected to be 
normal, cystic or neoplastic. 
Retrospectively in this study, the lateral development of TVT was indicated 
earlier on NIR than on grey-scale US. The marked vascularity enhancement of the TVT 
seen on Doppler is primarily in the periphery of the hypo-echoic TVT foci, but the 
elevation of [HbT] on NIR was found almost always distributed in the entire indicated 
TVT region. This is an indication that the attenuation of NIR light is directly associated 
with [HbT]. The NIR imaging may therefore detect the onset of neo-vasculature before 
the size of the vessels be detectable on other noninvasive imaging techniques such as 








In summary, the TRUS coupled trans-rectal NIR sagittal imaging probe was fabricated. 
The CW optical measurement demonstrated the quantitative estimation of the optical 
absorption coefficient is feasible when incorporating the TRUS a priori information. The 
use of a condom is found to have minimum effects on NIR tomography measurement. 
Absorptive targets can also be recognized by optical stand-alone reconstruction which 
demonstrates the potential of finding targets ambiguous to US imaging. 
In-vivo imaging of normal canine prostate and TVT tumors in the canine pelvic 
canal was performed by trans-rectal NIR tomography coupled with TRUS. The TVT 
tumor nodules were presented as hyper-absorption and hyper-scattering with respect to 
the normal prostatic and other pelvic tissues. Correlation of the TVT locations is found 
between trans-rectal NIR and TRUS images. 
Dual-band in-vivo imaging of canine prostate with TVT tumors demonstrated a 
non-invasive optical measurement of [HbT] changes associated with tumor development. 
Using trans-rectal US-coupled spectral optical tomography the development and lateral 
involvement of the prostate cancer was detected earlier than using TRUS alone. 
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7.1 Contributions of this work 
The most important contribution of this work is to demonstrate the in-vivo optical 
imaging of prostate by 3-stages of NIR/US development. It is the bridge to connect the 
NIR tomography with the non-invasive optical measurement of the prostate. The finding 
of the condom effect on light attenuation helps this imaging modality move on to future 
clinical study. The system calibration tests and in-vivo canine prostate measurements 
have demonstrated the potential to increase the specificity of prostate imaging by 
combining NIR optical and US measurement. 
This work focuses on the instrumentation and experimental demonstration. It 
involves hardware part fabrication, optical alignment, system integration, data calibration 
and imaging reconstruction. The instrumentation part includes the micro-optics related 
tools designing and assembling, source coupling setup, programming of the system 
control by Labview and developing the codes for data calibration and imaging 
reconstruction with respect to the specific test. The experimental demonstration covers all 
the tests designed to quantify the system performance and validate the potential on the 
clinical application. 
This work, to our knowledge, built the first combined endo-rectal NIR/US 
imaging applicator for prostate imaging. This integrated NIR/US prostate imaging 
platform which can be applied with those advanced techniques demonstrated on breast 
NIR imaging study such as frequency domain measurement or multiple-wavelength light 
to get further inclusions of the prostate optical properties. The dual-wavelength optical 
system is open to multiple wavelength measurement with minimum system changes. 
Future work is ongoing to validate the three-wavelength NIR imaging of mapping the 
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tissue oxygenation and perform in-vivo testing with TVT models developed in canine 
prostate. 
7.2 Challenges in future studies 
This work is an initial attempt to use the trans-rectal optical tomography in the 
prostate imaging field. A significant amount of work remains in order to apply this 
method in clinic such as required for the guidance in performing a biopsy. 
First of all, an accurate prostate cancer model is required for furthering this 
research on the human prostate cancer study. On US all of the TVT tumor nodules 
developed in this subject were shown to be strongly hypo-echoic that correlated with the 
strongly hyper-absorptive and moderately hyper-scattering findings on NIR imaging. The 
feature of TVT as strongly absorptive on NIR tomography is likely due to the hyper-
chromatic nuclei unique to TVT. The relatively higher scattering of the TVT may be due 
to the high density and larger nuclei of the neoplastic cells. As the neoplastic cells are 
arranged into microlobules by the pre-existing fibrovascular stroma, the TVT may also 
present certain polarization-sensitivity. Overall, the characteristic features of TVT on 
NIR tomography are comparable to those of angiogenesis that may be seen by NIR. 
Studies of microvessel density within the human prostate demonstrated a clear correlation 
of increased microvessel density with the presence of cancer. It is thereby a feasible 
expectation that the human prostate cancer may have notable contrast on trans-rectal NIR 
tomography. Most prostate cancers are presented as multi-focal. It must be noted that the 
intraprostatic TVT tumors were initiated in a non-immunosuppressed canine model in 
which the TVT nodules developed at multiple sites intra-prostatically and peri-
prostatically. Although not all TVT tumors were confined to the prostate, successful 
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imaging of multiple TVT nodules by trans-rectal NIR tomography implies the utility of 
detecting multiple intra-prostatic tumors. 
Secondly, there are several techniques demonstrated with great improvements that 
could be applied on this system to increase the reconstruction accuracy. As the discussion 
in section 4.3 states, incorporating the a priori spatial information can recover an 
accurate optical absorption and scattering value, while it needs the 3-D information from 
the US scanner in the clinical experiments. Other than that, a frequency-domain system 
can provide the phase information which helps to reconstruct the scattering values. It also 
can reduce the coupling issue of the reconstruction value between the absorption and 
scattering.  
For measuring the [HbT], a multiple wavelength or broadband measurement 
could be applied to the system. For multiple wavelengths, the solution of the [HbO] and 
[Hb] becomes a multiple linear regression problem. As describe in Equ. 2, the absorption 
is a wavelength dependant function of different chromphores, 
       
       



















        Equation 46 
Equation 45 could be symbolized as: 






























 is m×1 vector which is obtained from m-wavelength 
measurement. And  
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  is m×n matrix corresponding to 






















 is the molar concentration of n chromophores. 
The solution of Equ. 46 can be obtained by ordinary least squares (OLS) which is 
commonly used to analyze the experimental or observational data. 








           Equation 48 
One more advantage to use multiple wavelength and broadband measurement is 
that the incorporation of the spectral prior reconstruction provide by NIRFAST. In 
spectral prior reconstruction, the elements in Jacobian matrix are derived by Equ. 28. In 
the iteration, the chromophore concentration, scattering power and amplitude are updated 
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J  and J  are the original Jacobian matrix 














Studies have shown the spectral prior reconstruction give more accurate 
reconstructed results and stable reconstruction than the stand-alone optical reconstruction. 
Thirdly, the diffusion model based forward computation and iterative non-linear 
optimization of the image reconstruction of DOT is inevitably computationally 
expensive. Current image reconstruction of one wavelength data took about 10 minutes 
on a computer (Pentium 4, 3GHz, 2.5G RAM). Real-time optical image reconstruction is 
expected to apply this imaging modality to clinical exams. Recent work on the FEM 
solution to photon diffusion in biological tissue by implementing FPGA provides a 
potential to significant improve the reconstruction speed compared with current computer 
based image reconstruction. 
 
Figure 79 TRUS probe for human prostate imaging 
 
Last but not least, human prostate imaging is more challenging than canine 
prostate imaging. The ultrasound probe (Fig. 79) for human prostate imaging has 
different shape to the canine prostate imaging probe which is difficult to concurrent with 
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optical imaging plane. The dimension of the combined human prostate imaging 
applicator is more restricted than canine prostate imaging. And with more optical 
channels incorporated in human prostate imaging, the dramatically increased dynamic 
range of the received signals will be difficult to detect. When all those techniques can be 
applied to this trans-rectal US/NIR optical imaging system, the overall system 






[1] Jemal A, Siegel R, Ward E, Hao YP, Xu JQ, Murray T, Thun MJ, "Cancer Statistics, 
2008", CA Cancer J Clin 2008; 58: 71-96. 
[2] American Cancer Society: Cancer Facts and Figures 2009. Link: 
http://www.cancer.org/downloads/STT/500809web.pdf. 
[3] McNeal JE, Redwine EA, Freiha FS, Stamey TA, "Zonal distribution of prostatic 
adenocarcinoma. Correlaton with histologic pattern and direction of spread", Am J 
Surg Pathol 1988; 12: 897-906; 
[4] Andreas Erbersdobler, Herbert Augustin, Thorsten Schlomm and Rolf-peter Henke, 
―Prostate cancers in the transition zone: Part1; pathological aspects‖, BJU, 
International, 94, 1221-1225, 2004. 
[5] Herbert Augustin, Andereas Erbersdobler, Peter G. Hammerer, Markus Graefen and 
Hartwig Huland, ―Prostate cancers in the transition zone: Part2; clinical aspects‖, 
BJU International, 94, 1226-1229, 2004. 
[6] Ronald J. Cohen, Beverley A. Shannon, Michael Phillips, Rachael E. Moorin, 
Thomas M. Wheeler and Kerryn L. Garrett, ―Central Zone Carcinoma of the prostate 
Gland: A Distinct Tumor Type With Poor Prognostic Features‖, The Journal of 
Urology, Vol. 179, 1762-1767, May 2008. 
[7] Donald F. Gleason, George T. Mellinger and The veterans administration cooperative 
urological research group, ―Prediction of prognosis for prostatic adenocarcinoma by 
combined histological grading and clinical staging‖, J Urol 111: 58-64, 1974. 
[8] Gleason DF. Histologic grading and clinical staging of prostatic carcinoma. In: 
Tannenbaurn M, ed. Urologic Pathology: The prostate, Philadelphia: Lea & Febiger, 
1977; 171. 
[9] G. D. Grossfeld and P. R. Carroll, "Prostate cancer early detection: a clinical 
perspective," Epidemiol. Rev. 23, 173-80 (2001). 
[10] Kisbor Mistry and Greg Cable, ―Meta-Analysis of Porstate-Specific Antigen and 
Digital Rectal Examination as Screening Tests for Prostate Carcinoma‖, JABFP, Vol. 
16, No.2, 2003. 
120 
 
[11] Ian M. Thompson, Donna Pauler Ankerst, Chen Chi, M. Scott Lucia, Phyllis J. 
Goodman, John J. Crowley, Howard L. Parnes, Charles A. Coltman, ―Operating 
Characteristics of Prostate-Specific Antigen in Men with an Initial PSA Level of 
3.0ng/ml or Lower‖, JAMA., 294: 66-70, 2005. 
[12] Ian M. Thompson, Donna K. Pauler, Phyllis J. Goodman, Catherine M. Tangen, 
M. Scott Lucia, Howard L. Parnes, Lori M. Minasian, Leslie G. Ford, Scott M 
Lippman, E. David Crawford, John J. Crowley and Charles A. Coltman, ―Prevalence 
of Prostate Cancer among Men with a Prostae-Specific Antigen level ≤ 4.0 ng per 
Milliliter‖, The New England Journal of Medicine, 350:22, 39-46, 2004. 
[13] Aaron Caplan and Alexander Kratz, ―Prsotate-Specific Antigen and Early 
Diagnosis of Prostate Cancer‖, Am J. Clin. Pathol. (Suppl. 1: S104-S108), 2002. 
[14] C. R. Porter, "Does the number of prostate biopsies performed affect the nature of 
the cancer identified?", Nat. Clin. Pract. Urol. 4, 132-133 (2007). 
[15] V. Scattoni, A. Zlotta, R. Montironi, C. Schulman, P. Rigatti, and F. Montorsi, 
"Extended and saturation prostatic biopsy in the diagnosis and characterisation of 
prostate cancer: a critical analysis of the literature," Eur. Urol. 52,1309-1322 (2007). 
[16] Baris Turkbey, Peter A. Pinto and Peter L. Choyke, ―Imaging techniques for 
prostate cancer: implications for focal therapy‖, Nature review, Urology, Vol. 6, 191-
203, 2009. 
[17] A. C. Loch, A. Bannowsky, L. Baeurle, B. Grabski, B. König, G. Flier, O. 
Schmitz-Krause, U. Paul, and T. Loch, ―Technical and anatomical essentials for 
transrectal ultrasound of the prostate,‖ World J. Urol.25, 361-366 (2007). 
[18] Peter R. Carroll, Fergus V. Coakley and John Kurhanewicz, ―Magnetic 
Resonance Imaging and Spectroscopy of Prostate Cancer‖, Rev Urol. 8(Suppl. 1: S4-
S10), 2006. 
[19] Elizabeth Henderson, Michael F Milosevic, Masoom A Haider and Ivan W T 
Yeung, ―Functional CT imaging of prostate cancer‖, Phys. Med. Biol. 48 (3085-
3100), 2003. 
[20] Nobuyuki Oyama, Hironobu Akino, Hiroshi Kanamaru, Yuji Suzuki, Satoshi 
Muramoto, Yoshiharu Yonekura, Norihiro Sadato, Kazutaka Yamamoto and 
Kenichiro Okada, ―
11
C-Acetate PET Imaging of Prostate Cancer‖, J Nucl Med 2002, 
43:181-186. 
[21] Hodge KK, McNeal JE, Stamey TA, ―Ultrasound guided transrectal core biopsies 
of the palpably abnormal prostate,‖ J Urol.;142(1):66-70 (1989). 
121 
 
[22] Garber SJ, Goldenberg SL, Cooperberg PL, Wong AD, Bilby JH, Mathieson JR, 
―Systematic transrectal ultrasound-guided biopsy of the prostate,‖ Can Assoc Radiol 
J.; 45(5):387-90 (1994). 
[23] K. Shinohara, T. M. Wheeler, and P. T. Scardino, "The appearance of prostate 
cancer on trans-rectal ultrasonography: correlation of imaging and pathological 
examinations," J. Urol. 142, 76-82 (1989). 
[24] Ellis WJ, Brawer MK, ―The significance of isoechoic prostate carcinoma,‖ J. 
Urol,; 152: 2304-2307 (1994). 
[25] B. Spajic, H. Eupic, D. Tomas, G. Stimac, B. Kruslin, and O. Kraus, "The 
incidence of hyperechoic prostate cancer in trans-rectal ultrasound-guided biopsy 
specimens," Urology 70, 734-737 (2007). 
[26] Downs TM, Grossfield GD, Shinohara K, Carroll PR, ―Transrectal ultrasound-
guided prostate biopsy,‖ in Image-Guided Diagnosis and Treatment of Cancer, edited 
by D’Amico AV, Loefler JS, Harris JR,Human Press, 2003. 
[27] Newman JS, Bree RL, Rubin JM, ―Prostate cancer: diagnosis with color Doppler 
sonography with histologic correlation of each biopsy site,‖ Radiology; 195(1):86-90 
(1995). 
[28] Edmund Louvar, Peter J. Littrup, Albert Goldstein, Lelia Yu, Wael Sakr and 
David Grignon, ―Correlation of Color Doppler Flow in the Prostate with Tissue 
Microvascularity‖, Cancer, Vol. 83, No.1, July 1, 1998. 
[29] Wise AM, Stamey TA, McNeal JE, and Clayton JL, ―Morphologic and clinical 
significance of multifocal prostate cancers in radical prostatectomy specimens,‖ 
Urology 60, 264-9 (2002). 
[30] Mouraviev V, Mayes JM, Madden JF, Sun L, Polascik TJ, ―Analysis of laterality 
and percentage of tumor involvement in 1386 prostatectomized specimens for 
selection of unilateral focal cryotherapy,‖ Technol Cancer Res Treat, 2007. 
[31] M. A. Franceschini, K. T. Moesta, S. Fantini, G. Gaida, E. Gratton, H. Jess, W. 
W. Mantulin, M. Seeber, P. M. Schlag, and M. Kaschke, "Frequency-domain 
techniques enhance optical mammography: initial clinical results," Proc. Nat. Acad. 
Sci. USA 94, 6468-6473 (1997). 
[32] B. Tromberg, J. Coquoz, O. Fishkin, J. B. Pham, T. Anderson, E. R. Butler, J. 
Cahn, M. Gross, J. D.Venugopalan, and D. Pham, "Non-invasive measurements of 
breast tissue optical properties using frequency-domain photon migration," Phil. 
Trans. R. Soc. Lond. B 352, 661-668 (1997). 
122 
 
[33] B. W. Pogue, S. P. Poplack, T. O. McBride, W. A. Wells, K. S. Osterman, U. L. 
Osterberg, and K. D.Paulsen," Quantitative hemoglobin tomography with diffuse 
near-infrared spectroscopy: pilot results in the breast," Radiology 218, 261-266 
(2001). 
[34] V. Ntziachristos and B. Chance, "Probing physiology and molecular function 
using optical imaging: applications to breast cancer," Breast Cancer Res. 3, 41-46 
(2001). 
[35] Q. Zhu, E. B. Cronin, A. A. Currier, H. S. Vine, M. Huang, N. Chen, and C. Xu, 
"Benign versus malignant breast masses: optical differentiation with US-guided 
optical imaging reconstruction," Radiology 237, 57-66 (2005). 
[36] B. J. Tromberg, B. W. Pogue, K. D. Paulsen, A. G. Yodh, D. A. Boas, and A. E. 
Cerussi, ―Assessing the future of diffuse optical imaging technologies for breast 
cancer management,‖ Med Phys. 35, 2443-51 (2008). 
[37] Piao D, Jiang Z, Xu, G, Musgrove CH, Bunting CF, ―Approach on trans-rectal 
optical tomography probing for the imaging of prostate with trans-rectal ultrasound 
correlation‖, International Symposium on Biomedical Optics, San Jose, CA, Jan. 19-
24, 2008. Proceedings of SPIE, Vol. 6850, Paper #68500E (pages: 1-14) 
[38] Douglas E. Johnson, Douglas M. Cromeens and Roger E. Price, ―Interstitial laser 
prostatectomy‖, SPIE Vol. 2129, lasers in Urology 1994/67. 
[39] C. Li, R. Liengsawangwong, H. Choi, and R. Cheung , "Using a priori structural 
information from magnetic resonance imaging to investigate the feasibility of prostate 
diffuse optical tomography and spectroscopy: a simulation study," Med. Phys. 34, 
266-274 (2007). 
[40] M. Cutler, "Transillumination as an aid in the diagnosis of breast lesions," Surg. 
Gyn. Obst. 48, 721-729 (1929). 
[41] F. F. Jobsis, "Non-invasive, infra-red monitoring of cerebral and myochardial 
oxygen sufficiency and circulatory parameters," Science 198, 1264-1267 (1977). 
[42] Troy O. McBride, ―Spectroscopic Reconstructed Near Infrared Tomographic 
Imaging for Breast Cancer Diagnosis‖, Thesis, 2001. 
[43] S. Fantini, S. A. Walker, M. A. Franceschini, M. Kaschke, P. M. Schlag, and K. 
T.Moesta, "Assessment of the size, position, and optical properties of breast tumors 
in-vivo by noninvasive optical methods," Appl. Opt. 37, 1982-89 (1998). 
[44] T. O. McBride, B. W. Pogue, E. Gerety, S. Poplack, U. L. Osterberg, and K. D. 
Paulsen, "Spectroscopic diffuse optical tomography for quantitatively assessing 
hemoglobin concentration and oxygenation in tissue," Appl. Opt. 38, 5480-90 (1999). 
123 
 
[45] David A. Boas, Dana H. Brooks, Eric L. Miller, Charles A. DiMarzio, Misha 
Kilmer, Richard J. Gaudette and Quan Zhang, ―Imaging the body with Diffuse 
Optical Tomography‖, IEEE Signal Processing Magazine, 1053-5888/01, Nov. 2001. 
[46] Veronica S. Hollis, ―Non-Invasive Monitoring of Brain Tissue Temperature by 
Near-Infrared Spectroscopy‖, Thesis, Department of Medical Physics and 
Bioengineering, University College London, 2002. 
[47] Iyad S. Saidi, Steven L. Jacques, and Frank K. Tittel, ―Mie and Rayleigh 
modeling of visible-light scattering in neonatal skin‖, Applied optics, Vol. 34, No. 31, 
November 1995. 
[48] Michael Solonenko, Rex Cheung, Theresa M Busch, Alex Kachur, Gregory M 
Griffin, Theodore Vulcan, Timothy C Zhu, Hsing-Wen Wang, Stephen M Hahn and 
A G Yodh, ―In vivo reflectance measurement of optical properties, blood oxygenation 
and motexafin lutetium uptake in canine large bowels, kidneys and prostates‖, Phys. 
Med. Biol. 47 (2002) 857-873. 
[49] Srinivasan, S., Pogue, B.W., Carpenter C., Jiang, S., Wells, W.A., Poplack, S.P., 
Kaufman P.A. and Paulsen, K.D., ―Developments in Quantitative Oxygen-Saturation 
Imaging of Breast Tissue In-vivo Using Multispectral Near-Infrared Tomography‖, 
Antioxidants & Redox Signaling, 9(8): 1143-56 (2007). 
[50] T. Svensson, E. Alerstam,M. Einarsd´ott´ır,K. Svanberg, and S. Andersson-
Engels, ―Towards accurate in-vivo spectroscopy of the human prostate,‖ J. 
Biophoton., vol. 1, pp. 200–203, 2008. 
[51] L. V. Wang and Hi.-I Wu, ―Biomedical Optics: Principles and Imaging‖, Wiley, 
2007. 
[52] D. T. Delpy, M. Cope, P. van der Zee, S. Arridge, Susan Wray and J. Wyatt, 
―Estimation of optical pahtlength through tissue form direct time of flight 
measurement‖, Phys. Med. Biol. Vol.33, No. 12, 1433-1442, 1988. 
[53] S R Arridge, ―Topical review: Optical tomography in medical imaging‖, Inverse 
Problems 15, R41-R93, 1999. 
[54] A. P. Gibson, J. C. Hebden and S. R. Arridge, ―Recent advances in diffuse optical 
imaging‖, Topical review, Phys Med. Biol. 50, R1-R43, 2005. 
[55] H. Dehghani, M. E. Eames, P. K. Yalavarthy, S.C. Davis, S.Srinivasan, C. M. 
Carpenter, B.W. Pogue and K. D. Paulsen, ―Near infrared optical tomography using 
NIRFAST: Algorithm for numerical model and image reconstruction‖, Commun. 
Numer. Meth. Engng (2008). 
124 
 
[56] Heng Xu, ―MRI-coupled Broadband Near-infrared tomography for Small Animal 
Brain Studies‖, Thesis, Thayer School of Engineering, Dartmouth College, 2005. 
[57] M. S. Patterson, Chance B., Wilson, B. C., "Time resolved reflectance and 
transmittances for the non-invasive measurement of tissue optical properties," Appl. 
Opt. 28, 2331-2336 (1989). 
[58] B. Chance, Nioka, S., Kent, J., McCully, K., Fountain, M., Greenfield, R., 
Holtom, G., "Time-resolved spectroscopy of hemoglobin and myoglobin in resting 
and ischemic muscle," Analy. Biochem. 174, 698-707 (1988). 
[59] M. S. Patterson, Moulton, J. D., Wilson, B. C., Berndt, K. W., Lakowicz, J. R., 
"Frequency-domain reflectance for the determination of the scattering and absorption 
properties of tissue," Appl. Opt. 30, 4474-4476 (1991). 
[60] J. Fishkin, Gratton, E., van de Ven, M. J., Mantulin, W. W., "Diffusion of 
intensity modulated near infrared light in turbid media," Proc. SPIE 1431, 122-135 
(1991). 
[61] X. Zhou and T. C. Zhu, "Image reconstruction of continuous wave diffuse optical 
tomography (DOT) of human prostate," in Proc. the COMSOL Users Conference 
(2006) . 
[62] D. Piao, H. Xie. W. Zhang, J. S. Kransinski, G. Zhang, H. Dehghani, and B. W. 
Pogue, ―Endoscopic, rapid near-infrared optical tomography,‖ Opt. Lett. 31, 2876-
2878 (2006). 
[63] N. Iftimia and H. Jiang, ―Quantitative optical image reconstruction of turbid 
media by use of direct-current measurements,‖ Appl. Opt. 39, 5256-5261 (2000). 
[64] Z. Yuan, Q. Zhang, E. Sobel, and H. Jiang, ―Three-dimensional diffuse optical 
tomography of osteoarthritis: initial results in the finger joints,‖ J. Biomed. Opt. 12, 
034001 (2007). 
[65] Y. Xu, X.Gu, T. Khan and H. Jiang, ―Absorption and scattering images of 
heterogeneous scattering media can be simultaneously reconstructed by use of dc 
data‖, Applied Optics, Vol.41, No.25, Sep. 1, 2002. 
[66] Xu G, Piao D, Musgrove CH, Bunting CF, Dehghani H, ―Trans-rectal ultrasound-
coupled near-infrared optical tomography of the prostate Part I: Simulation,‖ Optics 
Express, Vol. 16, Iss. 22, pp. 17484–17504 (2008). 
[67] Zhang A, Piao D, Bunting CF, Pogue BW, ―Photon diffusion in a homogeneous 
medium bounded externally or internally by an infinitely long circular cylindrical 
applicator ---- Part I: steady-state theory,‖ Journal of Optical Society of America, A, 
Vol. 27, No. 3, pp. 648-662 (2010). 
125 
 
[68] McPhee MS, Thorndyke CW, Thomas G, et al.: Interstitial applications of laser 
irradiation in hematoporphyrin derivative-photosensitized Dunning R3327 prostate 
cancers. Lasers Surg Med 1984, 4:93–98. 
[69] Camps JL Jr, Powers SK, Beckman WC Jr, et al.: Photodynamictherapy of 
prostate cancer: an in vitro study. J Urol 1985, 134:1222–1226. 
[70] S. L. Jacques and M. Motamedi, ―Tomographic needles and catheters for optical 
imaging of prostatic cancer,‖ Proc. SPIE 2395, 111-118 (1995). 
[71] T. Svensson, S. Andersson-Engels, M. Einarsdóttír, and K. Svanberg, ―In-vivo 
optical characterization of human prostate tissue using near-infrared time-resolved 
spectroscopy," J. Biomed. Opt. 12, 014022 (2007). 
[72] Piao D, Bartels KE, Jiang Z, Holyoak GR, Ritchey JW, Xu G, Bunting CF, 
Slobodov G, ―Alternative trans-rectal prostate imaging: A diffuse optical tomography 
method,‖ IEEE Journal of Selected Topics in Quantum Electronics, ―Biophotonics 2‖ 
Special Issue. 
[73] L. K. Lee, C. Whitehurst,M. L. Pantelides, and J.V. Moore, ―An interstitial light 
assembly for photodynamic therapy in prostatic carcinoma,‖ BJU. Int., vol. 84, no. 7, 
pp. 821–826, 1999. 
[74] M. L. Pantelides, C.Whitehurst, J. V. Moore, T. A. King, and N. J. Blacklock, 
―Photodynamic therapy for localized prostatic cancer—Light penetration in the 
human prostate gland,‖ J. Urol. (Baltimore), vol. 143, no. 2, pp. 398–401, 1990. 
[75] C. Whitehurst, M. L. Pantelides, J. V. Moore, P. J. C. Brooman, and N. J. 
Blacklock, ―In-vivo laser-light distribution in human prostaticcarcinoma,‖ J. Urol. 
(Baltimore), vol. 151, no. 5, pp. 1411–1415, 1994. 
[76] L. K. Lee, C. Whitehurst, M. L. Pantelides, and J. V. Moore, ―In situ comparison 
of 665 nm and 633 nm wavelength light penetration in the human prostate gland,‖ 
Photochem. Photobiol., vol. 62, no. 5, pp. 882–886, 1995. 
[77] Wei, H., Xing D., He, B., Wu, R., Gu. H., Wu G., Chen, X., ―Absorption and 
Scattering Characteristics of Human Benign Prostatic Hyperplasia Tissue with Ti: 
Sapphire Laser Irradiation in Vitro‖, Spectroscopy and Spectral analysis (China), Vol. 
29, No.1, pp10-13, 2008. 
[78] T. C. Zhu, A. Dimofte, J. C. Finlay, D. Stripp, T. Busch, J. Miles, R.Whittington, 
S. B. Malkowicz, Z. Tochner, E. Glatstein, and S. M. Hahn, ―Optical properties of 
human prostate at 732 nm measured in mediated photodynamic therapy,‖ Photochem. 
Photobiol., vol. 81, no. 1, pp. 96–105, 2005. 
126 
 
[79] T. C. Zhu, J. C. Finlay, and S. M. Hahn, ―Determination of the distribution of 
light, optical properties, drug concentration, and tissue oxygenation in-vivo in human 
prostate during motexafin lutetiummediated photodynamic therapy,‖ J. Photochem. 
Photobiol. B, vol. 79, no. 3, pp. 231–241, 2005. 
[80] J. Li and T. C. Zhu, ―Determination of in-vivo light fluence distribution in a 
heterogeneous prostate during photodynamic therapy,‖ Phys. Med. Biol., vol. 53, no. 
8, pp. 2103–2114, Apr. 2008. 
[81] K. K. Wang and T. C. Zhu, ―Reconstruction of in-vivo optical properties for 
human prostate using interstitial diffuse optical tomography,‖ Opt. Exp., vol. 17, no. 
14, pp. 11665–11672, 2009. 
[82] R. A. Weersink, A. Bogaards, M. Gertner, S. R. H. Davidson, K. Zhang, G. 
Netchev, J. Trachtenberg, and B. C. Wilson, ―Techniques for delivery and monitoring 
of TOOKAD _WST09_-mediated photodynamic therapy of the prostate: Clinical 
experience and practicalities,‖ J. Photochem. Photobiol. B, vol. 79, no. 3, pp. 211–
222, 2005. 
[83] M. Essenpreis, ―Thermally induced changes in optical properties of biological 
tissues,‖ Ph.D. thesis, Univ. College London, London, 1992. 
[84] A. Roggan, K. D¨orschel, O. Minet, D.Wolff, and G.M¨uller, ―The optical 
properties of biological tissue in the near infrared wavelength range—review and 
measurements,‖ in Laser-induced Interstitial Thermotherapy Thermotherapy, G. 
M¨uller and A. Roggan, Eds.:Washington: SPIE Optical Engineering Press, 1995, pp. 
10–44. 
[85] Dheerendra Kashyap, Disha Peswani, Jeffrey Cadeddu and Hanli Liu, ―Steady-
state reflectance spectroscopy used to quantify hemodynamic and optical properties 
of tissue: Demonstration of heterogeneities of human prostrates‖, BIOMED, BSuE80, 
2008. 
[86] Franceschini, M. A., Joseph, D. K., Huppert, T. J., Diamond, S. G. and Boas, D. 
A. (2006). "Diffuse optical imaging of the whole head." Journal Biomed Optics 
11(5): 054007. 
[87] Gultekin Gulsen, Bin Xiong, Ozlem Birgul and Orhan Nalcioglu, ―Design and 
implementation of a multifrequency near-infrared diffuse optical tomography 
system‖, Journal of Biomedical Optics, Vol. 11(1), 2006. 
[88] T. O. Mcbride, B. W. Pogue, S. Jiang, U. L. Osterberg, K. D. Paulsen, ―A 
parallel-detection frequency-domain near-infrared tomography system for 
hemoglobin imaging of the breast in-vivo‖, Rev. Sci. Instrum., volume 72, 2001. 
127 
 
[89] Chen, NG, Huang, MM, Xia, HJ, Piao, DQ, Cronin, E, Zhu, Q., "Potable near 
infrared diffusive light imager for breast cancer detection," Journal of Biomedical 
Optics, MAY/JUNE ISSUE, 504-510, 2004. 
[90] Jiang Z, Xu G, Elgawadi A, Piao D, ―Development of a trans-rectal optical 
tomography probe for concurrent sagittal imaging with trans-rectal ultrasound‖, OSA 
Biomedical Topical Meetings, St. Petersburg, FL. March 16-19, 2008. 
[91] Jiang Z, Piao D, Xu G, Ritchey JW, Holyoak GR, Bartels KE, Bunting CF, 
Slobodov G, Krasinski JS, ―Trans-rectal ultrasound-coupled near-infrared optical 
tomography of the prostate Part II: Experimental demonstration,‖ Optics Express, 
Vol. 16, Iss. 22, pp. 17505–17520 (2008). 
[92] Piao D, Xie H. Zhang W, Kransinski JS, Zhang G, Dehghani H, and Pogue BW, 
―Endoscopic, rapid near-infrared optical tomography‖, Optics Letters, Vol. 31, No. 
19, Oct. 2006, pp.  2876-2878. 
[93] Piao D, Dehghani H, Jiang S, Srinivasan S, and Pogue BW, ―Instrumentation for 
video-rate near-infrared diffuse optical tomography‖, Review of Scientific 
Instruments, Vol. 76, No. 12, Dec. 2005, pp. 124301-124301-13. 
[94] Piao D, Jiang S, Srinivasan S, Dehghani H, and Pogue BW, ―Video-rate near-
infrared optical tomography using spectrally-encoded parallel light delivery‖, Optics 
Letters, Vol. 30, No. 19, Oct. 2005, pp. 2593-2595. 
[95] M. J. Holboke, B. J. Tromberg, X. Li, N. Shah, J. Fishkin, D. Kidney, J. Butler, B. 
Chance, and A. G.Yodh, ―Three-dimensional diffuse optical mammography with 
ultrasound localization in a human subject,‖ J. Biomed Opt. 5, 237-247 (2000). 
[96] M. Guven, B. Yazici, X. Intes, and B. Chance, ―Diffuse optical tomography with 
a priori anatomical information,‖ Phys. Med. Biol. 50, 2837-58 (2005). 
[97] H. Dehghani, C. M. Carpenter, P. K. Yalavarthy, B. W. Pogue, and J. P. Culver, 
―Structural a priori information in near-infrared optical tomography,‖ Proc. SPIE 
6431, 64310B1-7 (2007). 
[98] Musgrove, C., Bunting, C.F., Dehghani, H., Pogue, B.W. and Piao, D., 
―Computational Aspects of Endoscopic (Trans-rectal) Near-infrared Optical 
Tomography: Initial Investigations‖, Proc. SPIE, 6434, 643409 (2007). 
[99] Hao Xie, ―Dual-spectral endoscopic near-infrared optical tomography for 
assessment of Hemoglobin concentration and oxygen saturation‖, Thesis, Oklahoma 
State University, 2008. 
128 
 
[100] S. Arridge, M. Cope, and D. Delpy, ―The theoretical basis for the determination 
of optical path-length in tissue: temporal and frequency analysis,‖ Phys. Med. Biol. 
Vol. 37, No 7, 1531-1560 (1992). 
[101] R. C. Haskell, L. O. Svaasand, T. T. Tsay, T. C. Feng, M. S. McAdams, B. J. 
Tromberg, ―Boundary conditions for the diffusion equation in radiative transfer,‖ J. 
Opt. Soc. Am. A. 11, 2727-41 (1994). 
[102] R. Aronson, ―Boundary conditions for diffusion of light,‖ J. Opt. Soc. Am. A. 12, 
2532-9 (1995). 
[103] A. H. Hielscher, R. E. Alcouffe, and R. L. Barbour, ―Comparison of finite-
difference transport and diffusion calculations for photon migration in homogeneous 
and heterogeneous tissues,‖ Phys. Med. Biol. 43, 1285-302 (1998). 
[104] Wai-Fung Cheong, Scott A. Prahl and Ashley J. Welch, ―A review of the Optical 
Properties of Biological Tissues‖, IEEE Journal of Quantum Electronics, Vol. 26, 
No.12, Dec. 1990. 
[105] B. Rivera, K. Ahrar, M.M. Kangasniemi, J.D. Hazle and R.E. Price, ―Canine 
Transmissible Venereal Tumor: A Large-Animal Transplantable Tumor Model‖, 
Comparative Medicine, Vol. 55, No. 4, Aug 2005. 
[106] Piao D, Jiang Z, Bartels KE, Holyoak GR, Ritchey JW, Xu G, Bunting CF, 
Slobodov G, ―In-vivo trans-rectal ultrasound-coupled near-infrared optical 
tomography of intact normal canine prostate,‖ Journal of Innovative Optical Health 
Sciences, Vol. 2, No. 3, pp. 215-225 (2009). 
[107] Jiang Z, Holyoak GR, Bartels KE, Ritchey JW, Xu G, Bunting CF, Slobodov G, 
Piao D, ―In-vivo trans-rectal ultrasound coupled near-infrared optical tomography of a 
transmissible venereal tumor model in the canine pelvic canal,‖ Journal of 
Biomedical Optics Letters, Vol. 14, No. 3, pp. 030506, May/June, 2009. 
[108] R. Choe, A. Corlu, K. Lee, T. Durduran, S. D. Konecky, M. Grosicka-Koptyra, S. 
R. Arridge, B. J. Czerniecki, D. L. Fraker, A. DeMichele, B. Chance, M. A. Rosen, 
and A. G. Yodh, "Diffuse optical tomography of breast cancer during neoadjuvant 
chemotherapy: a case study with comparison to MRI," Med. Phys. 32, 1128-1139 
(2005). 
[109] Jiang Z, Ritchey JW, Holyoak GR, Bartels KE, Xu G, Bunting CF, Slobodov G, 
Krasinski JS, Piao D, ―In-vivo trans-rectal ultrasound coupled trans-rectal near-
infrared optical tomography of canine prostate bearing transmissible venereal tumor,‖ 
International Symposium on Biomedical Optics, San Jose, CA, Jan. 24-29, 2009. 
Proceedings of SPIE, Vol. 7174, Paper #71741U. 
129 
 
[110] Newman JS, Bree RL, Rubin JM, ―Prostate cancer: diagnosis with color Doppler 
sonography with histologic correlation of each biopsy site,‖ Radiology; 195(1):86-90 
(1995). 
[111] Bigler SA, Deering RE, Brawer MK, ―Comparison of microscopic vascularity in 
benign and malignant prostate tissue,‖ Hum Pathol. 1993 Feb;24(2):220-6. 
[112] Cosgrove D, ―Angiogenesis imaging—ultrasound,‖ Br J Radiol. 2003;76 Spec No 
1:S43-9. Review. 
[113] Halpern JE, ―Color and power Doppler evaluation of prostate cancer,‖ in Imaging 
of the Prostate, edited by Halpern RJ, Cochlin DL, Goldberg BB, Martin Dunitz, 
2002. 
[114] Chance B., Nika S., Zhang J., Conant E.F., Hwang E., Briest S., Orel S.G., 
Schnall M.D., and Czerniecki B.J., ―Breast cancer detection based on incremental 
biochemical and physiological properties of breast cancers: a six-year, two-site 
study‖, Acad Radiol., 12: 925-933 (2005). 
[115] Vollmer, R.T., Kantoff, P.W., Dawson, N.A. and Vogelzang, N.J., ―Importance of 
Serum Hemoglobin in Hormone Refractory Prostate Cancer‖, Clinical Cancer 
Research, 8: 1049-1053 (2002). 
[116] Yu, G., Durduran, T., Zhou, C., Zhu, T.C., Finlay, J.C., Busch, T.M., Malkowicz, 
S.B., Hahn, S.M. and Yodh, A.G., ―Real-time In situ Monitoring of Human Prostate 
Photodynamic Therapy with Diffuse Light‖, Photochemistry and Photobiology, 82: 
1279-1284 (2006). 
[117] Beer, T.M., Tangen, C.M., Bland, L.B., Hussain, M., Goldman, B.H., 
DeLoughery, T.G. and Crawford, E.D., ―The prognostic value of Hemoglobin change 
after initiating Androgen-Deprivation therapy for newly diagnosed metastatic prostate 
cancer‖, Cancer, 107(3):489-96  (2006). 
[118] Jiang Z, Piao D, Krasinski JS, ―Development of a continuous-wave dual-band 
trans-rectal optical tomography system for concurrent sagittal imaging with trans-
rectal ultrasound,‖ International Symposium on Biomedical Optics, San Jose, CA, 
Jan. 24-29, 2009. Proceedings of SPIE, Vol. 7171, Paper #71710G. 
[119] McCay CM, ―The hemoglobin and total phosphorus in the blood of cows and 
bulls,‖ J. Dairy Sei., 14 (4): 373-378 (1931). 
[120] Hayes MD, Vanzant ES, Stombaugh TS, Gates RS, ―Comparison of bovine blood 




[121] Karen B. and Atle B., ―Accurate de-oxygenation of ex vivo whole blood using 
sodium dithionite‖, Proc. Intl. Soc. Mag. Reson. Med. 8 (2000). 
[122] Justin Rajesh Rajian, Paul L. Carson and Xueding Wang, ―Quantitative photo-
acoustic measurement of tissue optical absorption spectrum aided by an optical 







A.1 Measured absorption value of intralipid with different ink concentration 
 
For 1% and 0.2% intralipid, each solution was prepared 0.1% (ink/intralipid) solution 
(Pelikan Schwarz – black) and measured by spectrophotometer. That is: 







After that, prepared 150ml 1% intralipid and 150ml 0.2% intralipid, added with 
the 0.1% ink/intralipid solution to increase the absorption. 
Table 10 Absorption value of 1% intralipid (cm
-1
) 150ml 
0.1%ink 650nm 705nm 750nm 785nm 808nm 
0 -0.001 0 0 -0.001 -0.001 
1ml 0.077 0.067 0.058 0.053 0.051 
2ml 0.172 0.152 0.135 0.125 0.12 
3ml 0.224 0.195 0.172 0.158 0.151 
4ml 0.292 0.256 0.226 0.209 0.199 
5ml 0.348 0.306 0.27 0.249 0.238 





Table 11 Absorption value of 0.2% intralipid (cm
-1
) 150ml 
0.1%ink 650nm 705nm 750nm 785nm 808nm 
0 -0.001 0.001 0.003 0.002 0.002 
1ml 0.027 0.025 0.024 0.023 0.022 
2ml 0.055 0.050 0.046 0.043 0.041 
3ml 0.084 0.075 0.068 0.063 0.060 
4ml 0.11 0.097 0.088 0.082 0.078 
5ml 0.135 0.12 0.108 0.099 0.094 




A.2 Pin definition of TCLDM9 and LDR 
 
Table 12 Pin definition of TCLDM9 Laser diode driver 
Pin Signal Description 
1 Interlock and Status Pin 
(LDC Specific) 
This pin is the input to the LD Status Indicator and 
Interlock Circuits. When using Thorlabs LDCs no 
external circuitry is required. To use these features with 
third-party controllers please refer to the Status and 
Interlock section of this manual. 
5 Interlock and Status 
Return 
This pin is the return side of the Status and Interlock 
circuitry. 
7 Laser Diode Cathode This pin is connected to the 3 o’clock pin on the laser 
socket when the LD Polarity Switch is set to AG (Anode 
Grounded). Otherwise it is floating. 
8 Laser Diode Anode This pin is connected to the 3 o’clock pin on the laser 
socket when the LD Polarity Switch is set to CG 
(Cathode Grounded). Otherwise it is floating. 
3 Laser Ground (Case) This pin is connected to the 12 o’clock and 6 o’clock 
pins on the laser socket and corresponds to the settings 
of the LD and PD polarity switches. i.e. If the LD and 
PD switches are set to AG then this pin grounds the 
Anodes of the laser and photo diodes. 
2 Photodiode Cathode This pin is connected to the 9 o’clock pin on the laser 
socket when the PD Polarity Switch is set to AG (Anode 
Grounded). It is attached to ground and the 12 o’clock 
and 6 o’clock pins on the laser socket when the PD 
Polarity Switch is set to CG (Cathode Grounded). 
4 Photodiode Anode This pin is connected to the 9 o’clock pin on the laser 
socket when the PD Polarity Switch is set to CG 
(Cathode Grounded). It is attached to ground and the 12 
o’clock and 6 o’clock pins on the laser socket when the 
PD Polarity Switch is set to AG (Anode Grounded). 
6 Laser Diode Voltage 
(Cathode) 
This pin is connected to LD Interface Pin 7, thru a 499 
Ohm resistor, when the LD Polarity Switch is set to AG 
(Anode Grounded). It is attached directly to LD 
Interface Pin 3 when the LD Polarity Switch is set to CG 
(Cathode Grounded). 
9 Laser Diode Voltage 
(Anode) 
This pin is connected to LD Interface Pin 8, thru a 499 
Ohm resistor, when the LD Polarity Switch is set to CG 
(Cathode Grounded). It is attached directly to LD 
Interface Pin 3 when the LD Polarity Switch is set to 




Table 13 Pin definition of TCLDM9 Laser temperature controller 
Pin Signal Description 
4 +TEC This pin is connected to the positive terminal of the TEC element. 
5 -TEC and 
TEC Lockout 
(-) 
This pin is connected to the negative terminal of the TEC element, 
and also is common to the cathode of the photo-relay of the TEC 
Lockout circuit - refer to the Status and Interlock section of this 
manual. 
1 TEC Lockout 
(+) 
This pin is connected to the anode of the photo-relay side of the 
TEC Lockout circuit. When using Thorlabs TEDs no external 
circuitry is required. To use these features with third-party 
controllers please refer to the Status and Interlock section of this 
manual. 
2 +Thermistor The 10KΩ @ 25°C NTC thermistor (provided for temperature 
feedback). 
3 -Thermistor The thermistor return pin. 
7 AD592(-) The negative terminal of the AD592 temperature transducer. When 
using Thorlabs TEDs no external circuitry is required. To use this 
device with third party controllers it must be properly biased. 
Refer to Analog Devices AD592 Data for application information. 
9 AD592(+) The positive terminal of the AD592 
6 n.c.  
8 n.c.  
 
The rear panel connectors of LD driver and TEC are shown in Fig. 79. The LD 
driver connector pins are regularly defined. In order for the laser output to be enabled, a 
short must exist between the Inter lock pins (1, 2) of the connector. The short can be a 
direct short across the pins or a switch to prevent laser operation until the switch is 
closed. Otherwise, the Interlock LED illuminates on the front panel and the laser output is 
disabled. For TEC connector, Pins 1 and 2, 3 and 4 are connected together in pairs 
internally to allow high current flow to the TEC module. Pins 7 and 8 are connected to 
the sensor. Pins 9 through 15 (Right side pins), which are designed for use with an 




Figure 80 Rear panel connector of LDC-3722B 
The connections between the LD drivers and TEC drivers are shown in Fig. 80 




Figure 81 Connection between the LD drivers 
 
 
Figure 82 Connection between the TEC drivers 
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A.3 Matlab codes 
 
Spectral-encoded system CCD image data calibration           Cal_hb.m 
Optical reconstruction without a priori    recon_no_prior_bat.m 
Build matlab mesh from comsol file with homogeneous absorption and scattering  
                  Make_comsol_mesh.m 
Time-multiplex system CCD data acquisition (three wavelengths) from 7 frames  
              getdata_mimages_3wv.m 
Time-multiplex system CCD data acquisition (three wavelengths) from 1 frames  
                  get_3wv_data.m 
Time-multiplex system CCD acquired data calibration          Datafit_switch.m 
Data fit to the reconstruction mesh       Cal_switch_nobak.m 
Plot [HbT] and StO2 images (2 wavelengths)      show_2wv.m 





function [data_reshape_b roi]=Cal_hb(b1,b2,er,nb) 
% b1 is the first measurement, b2 is the last measurement; 
G_b=30; %Gaussian fit bandwidth/2; 
%% First calibrate background; 
hb_t=zeros(512,512); 
for i=b1:b2 
    b_fn=strcat('b',num2str(i),'_1.txt'); 
    b1_1=load(b_fn); 
    hb_t=hb_t+b1_1(:,2:513); 
    clear b1_1 b_fn; 
end; 
hb1=hb_t/(b2-b1+1); %homogeneous background; 
hb=hb1-nb; %nb is noise level; 
clear hb_t hb1 min_hb bs be; 
  
% pick up the 49 region of interest; 
% Find detector first; 
bd=30; %half of bandwidth of detecter to seperate 




    dm(i)=max(d_mean); 
    d_center(i)=find(d_mean==max(d_mean)); 




roi.dc=zeros(1,7); % center of detector; 
roi.dw=zeros(1,7); % half of FWHM of Gaussian pulse; 
for i=1:7 
    x=(d_center1(i)-G_b):(d_center1(i)+G_b); 
    x=x'; 
    y=d_mean(x); 
    [g_a g_b g_c]=Gaussian_fit(x,y); 
    roi.dc(i)=round(g_b); 
    roi.dw(i)=round(sqrt(g_c*log(2))); 
    clear x y; 
end; 
clear dm bd d_center d_center1 dm g_a g_b g_c; 
  
% Second find source; 
s_center=zeros(1,7); 
s_mean=mean(hb,1); %mean value along the source; 





    sm(i)=max(s_mean); 
    s_center(i)=find(s_mean==sm(i)); 
    if (s_center(i)-bs)<1 
        x_min=1; 
    else x_min=s_center(i)-bs; 
    end; 
    if (s_center(i)+bs)>512 
        x_max=512; 
    else x_max=s_center(i)+bs; 
    end; 




roi.sc=zeros(7,7); % center of detector; 
roi.sw=zeros(1,7); % half of FWHM of Gaussian pulse; 
for i=1:7 
    x=(s_center1(i)-G_b):(s_center1(i)+G_b); 
    y=s_mean(x); 
    [g_a g_b g_c]=Gaussian_fit(x,y); 
    roi.sc(:,i)=round(g_b); 
    roi.sw(i)=round(sqrt(g_c*log(2))); 
    clear x y; 
end; 




    for s=1:7; 
        data_aver(d,s)=sum_ellipse(hb,roi.sc(d,s),... 
            roi.dc(d),roi.sw(s),roi.dw(d),er); 
    end; 
end; 
data_reshape_b=fliplr(circshift(data_aver,[0,-3]))'; 
clear G_b bs d d_mean data_aver hb i j jj rj s s_center s_center1 s_center_offset s_mean 
s_temp s_temp_mean sm; 
 









clear; clc; close all; 
 
% Read out the calibration file. 
load('roi.mat'); 
 




% mi is the measured data sets at each locations 
for c_i=1:18 
    switch c_i 
        case {1} 
            content='Left_caudal_'; 
            mi=4; 
        case {2} 
            content='Left_cranial_'; 
            mi=6; 
        case {3} 
            content='Left_edge_caudal_'; 
            mi=4; 
        case {4} 
            content='Left_edge_cranial_'; 
            mi=5; 
        case {5} 
            content='Left_edge_mid_'; 
            mi=4; 
        case {6} 
            content='Left_mid_'; 
            mi=4; 
        case {7} 
            content='Left_muscle_'; 
            mi=3; 
        case {8} 
            content='Midline_caudal_'; 
            mi=5; 
        case {9} 
            content='Midline_cranial_'; 
            mi=4; 
        case {10} 
            content='Midline_mid_'; 
            mi=5; 
        case {11} 
            content='Right_edge_caudal_'; 
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            mi=4; 
        case {12} 
            content='Right_edge_cranial_'; 
            mi=4; 
        case {13} 
            content='Right_edge_mid_'; 
            mi=4; 
        case {14} 
            content='Right_mid_caudal_'; 
            mi=4; 
        case {15} 
            content='Right_mid_cranial2_'; 
            mi=4; 
        case {16} 
            content='Right_mid_cranial_'; 
            mi=4; 
        case {17} 
            content='Right_mid_mid_'; 
            mi=6; 
        case {18} 
            content='Right_muscle_'; 
            mi=4; 
    end; 
    for meas_i=1 :mi 
        fn_t=strcat(data_fold,content,num2str(meas_i)); 
        [t1 t2 t3]=getdata_mimages_3wv(fn_t,roi); 
        data_1=(t1-roi.w1.noise).*roi.w1.cal; 
        data_2=(t2-roi.w2.noise).*roi.w2.cal; 
        data_3=(t3-roi.w3.noise).*roi.w3.cal; 
         
%% Fitting background 
        mesh_recon_fn='mesh_r'; 
        mesh_fd_fn='mesh_f'; 
        delete *mesh_f_mesh* *mesh_r_mesh*; 
        Make_comsol_mesh(mesh_fd_fn,0.007,1.0); % 1% intralipid with solution ink). 
        mesh=load_mesh('mesh_f_mesh'); 
        [mua_b_1 mus_b_1]=fit_slope(data_1,mesh,0); 
        if mua_b_1<0.0025 
            mua_b_1=0.0025; 
        end; 
        clear mesh; 
         
        mesh=load_mesh('mesh_f_mesh'); 
        [mua_b_2 mus_b_2]=fit_slope(data_2,mesh,0); 
        if mua_b_2<0.0025 
            mua_b_2=0.0025; 
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        end; 
        clear mesh; 
         
        mesh=load_mesh('mesh_f_mesh'); 
        [mua_b_3 mus_b_3]=fit_slope(data_3,mesh,0); 
        if mua_b_3<0.0025 
            mua_b_3=0.0025; 
        end; 
        clear mesh; 
 
%% Reconstruction for 1
st
 wavelength; 
        delete *mesh_r_mesh* *mesh_f_mesh*; 
        Make_comsol_mesh(mesh_fd_fn,mua_b_1,mus_b_1); 
        Make_comsol_mesh(mesh_recon_fn,mua_b_1,mus_b_1); 
        delete *w1.paa*; 
        mesh=load_mesh('mesh_f_mesh'); 
        Cal_switch_nobak(mesh, data_1, 0, 'w1.paa'); close; 
        clear mesh data_1; 
         
        out_fn_1=strcat(content,num2str(meas_i),'_1_out'); 
        regular=1; 
        [mesh,pj_error,it] = 
reconstruct_stnd_0('mesh_f_mesh','mesh_r_mesh',0,'w1.paa',10,regular,out_fn_1,0); 
        clear mesh pj_error; 
        while it<5 
            regular=2*regular; 
            [mesh,pj_error,it] = 
reconstruct_stnd_0('mesh_f_mesh','mesh_r_mesh',0,'w1.paa',10,regular,out_fn_1,0); 
        clear mesh pj_error 
        end; 
         
%% Reconstruction for 2nd wavelength; 
        delete *mesh_r_mesh* *mesh_f_mesh*; 
        Make_comsol_mesh(mesh_fd_fn,mua_b_2,mus_b_2); 
        Make_comsol_mesh(mesh_recon_fn,mua_b_2,mus_b_2); 
        delete *w2.paa*; 
        mesh=load_mesh('mesh_f_mesh'); 
        Cal_switch_nobak(mesh, data_2, 0, 'w2.paa'); close; 
        clear mesh data_2; 
         
        out_fn_2=strcat(content,num2str(meas_i),'_2_out'); 
        regular=1; 
        [mesh,pj_error,it] = 
reconstruct_stnd_0('mesh_f_mesh','mesh_r_mesh',0,'w2.paa',10,regular,out_fn_2,0); 
        clear mesh pj_error; 
        while it<5 
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            regular=2*regular; 
            [mesh,pj_error,it] = 
reconstruct_stnd_0('mesh_f_mesh','mesh_r_mesh',0,'w2.paa',10,regular,out_fn_2,0); 
        clear mesh pj_error; 
        end; 
         
%% Reconstruction for 3
rd
 wavelength; 
        delete *mesh_r_mesh* *mesh_f_mesh*; 
        Make_comsol_mesh(mesh_fd_fn,mua_b_3,mus_b_3); 
        Make_comsol_mesh(mesh_recon_fn,mua_b_3,mus_b_3); 
        delete *w3.paa*; 
        mesh=load_mesh('mesh_f_mesh'); 
        Cal_switch_nobak(mesh, data_3, 0, 'w3.paa'); close; 
        clear mesh; 
         
        out_fn_3=strcat(content,num2str(meas_i),'_3_out'); 
        regular=1; 
        [mesh,pj_error,it] = 
reconstruct_stnd_0('mesh_f_mesh','mesh_r_mesh',0,'w3.paa',10,regular,out_fn_3,0); 
        clear mesh pj_error; 
        while it<5 
            regular=2*regular; 
            [mesh,pj_error,it] = 
reconstruct_stnd_0('mesh_f_mesh','mesh_r_mesh',0,'w3.paa',10,regular,out_fn_3,0); 
        clear mesh pj_error; 
        end; 




















    if (domain(j)==1 || domain(j)==2 || domain(j)==3) 
        for i=1:4 
            region_tmp(elements(j,i)+1)=1; 
        end 




    if (domain(j)==2 || domain(j)==3) 
        for i=1:4 
            region_tmp(elements(j,i)+1)=2;%prostate+blob 
        end 




    if (domain(j)==3) 
        for i=1:4 
            region_tmp(elements(j,i)+1)=3;%bg 
        end 



































mesh.source.coord(1,:)=[10 25 0]; 
mesh.source.coord(2,:)=[20 25 0]; 
mesh.source.coord(3,:)=[30 25 0]; 
mesh.source.coord(4,:)=[40 25 0]; 
mesh.source.coord(5,:)=[50 25 0]; 
mesh.source.coord(6,:)=[60 25 0]; 
mesh.source.coord(7,:)=[70 25 0]; 
  
  
mesh.meas.coord(1,:)=[10 45 0]; 
mesh.meas.coord(2,:)=[20 45 0]; 
mesh.meas.coord(3,:)=[30 45 0]; 
mesh.meas.coord(4,:)=[40 45 0]; 
mesh.meas.coord(5,:)=[50 45 0]; 
mesh.meas.coord(6,:)=[60 45 0]; 
mesh.meas.coord(7,:)=[70 45 0]; 
  
 for i=1:7 
    mesh.link(i,:)=1:7; 
end; 





 From imaging top to bottom is detector 1 2 3 4 5 6 7; detector 1 is on 
% the top of the probe, detector 7 is closest to the handle. 
% The sequence of the switch is Source 4 5 6 7 1 2 3 according to the 
% position 1 2 3 4 5 6 7 (start - end) equal to source 4 5 6 7 1 2 3; 
% Get each measurement for 7 images; 
% fn_t is the measurement data converted from the *.spe to *.txt; 
% roi is the location of the data spot on one image; 
  
function [data1, data2, data3]=getdata_mimages_3wv(fn_t, roi) 
n=length(roi.w1.dx); 
data1_t=zeros(n,n); data2_t=zeros(n,n); data3_t=zeros(n,n); 
for i=1:n 
    t_fn=strcat(fn_t,'_',num2str(i),'.txt'); 







data1=zeros(n*n,1); data2=zeros(n*n,1); data3=zeros(n*n,1); 
for i=1:n 
    for j=1:n 
        data1((i-1)*n+j)=data_reshape_1(i,j); 
        data2((i-1)*n+j)=data_reshape_2(i,j); 
        data3((i-1)*n+j)=data_reshape_3(i,j); 






% Get 3 wave data from single measurement; 
% From imaging top to bottom is detector 1 2 3 4 5 6 7; detector 1 is on 
% the top of the probe, detector 7 is closest to the handle. 
% fn_t is the measurement data matrix 
% roi is the location of the spot center and radius on one image; 
% noise will be removed after function. Counted as 2 times mini-number. 
  




























    %Check if the signal is too weak for wavelength1; 
    
[s,pixel]=sum_ellipse_noise(meas,roi.w1.dx(i),roi.w1.dy(i),roi.w1.rx(i),roi.w1.ry(i),1,0); 
    if s>=(pixel*signal_base) 
        signal_power1(i)=1; 
    end; 
     
    
[s,pixel]=sum_ellipse_noise(meas,roi.w2.dx(i),roi.w2.dy(i),roi.w2.rx(i),roi.w2.ry(i),1,0); 
    if s>=(pixel*signal_base) 
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        signal_power2(i)=1; 
    end; 
     
    
[s,pixel]=sum_ellipse_noise(meas,roi.w3.dx(i),roi.w3.dy(i),roi.w3.rx(i),roi.w3.ry(i),1,0); 
    if s>=(pixel*signal_base) 
        signal_power3(i)=1; 












% Locate the y coordinate for each image; 
for i=1:n 
    if ~roi_new.w1.sp(i) 
        roi_new.w1.dy(i)=roi.w1.dy(i); 
        roi_new.w1.ry(i)=roi.w1.ry(i); 
        roi_new.w1.dx(i)=roi.w1.dx(i); 
        roi_new.w1.rx(i)=roi.w1.rx(i); 
    else 
        temp_band=25; 
        temp_x=roi.w1.dy(i)-temp_band:roi.w1.dy(i)+temp_band; 
        temp_x=temp_x'; 
%         temp_data=ave_1(temp_x); 
%         [g_a g_b g_c]=Gaussian_fit(temp_x,temp_data); 
%         roi_new.w1.dy(i)=round(g_b); 
        roi_new.w1.dy(i)=roi.w1.dy(i); 
        roi_new.w1.ry(i)=roi.w1.ry(i); 
         
        temp_image=image_1(temp_x,:); 
        temp_data=mean(temp_image); 
        temp_x=1:length(temp_data); 
        [g_a g_b g_c]=Gaussian_fit(temp_x,temp_data); 
        roi_new.w1.dx(i)=round(g_b)+xcenter1-rx1_sep-1; 
        roi_new.w1.rx(i)=roi.w1.rx(i); 
    end; 
     
    if ~roi_new.w2.sp(i) 
        roi_new.w2.dy(i)=roi.w2.dy(i); 
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        roi_new.w2.ry(i)=roi.w2.ry(i); 
        roi_new.w2.dx(i)=roi.w2.dx(i); 
        roi_new.w2.rx(i)=roi.w2.rx(i); 
    else 
        temp_band=25; 
        temp_x=roi.w2.dy(i)-temp_band:roi.w2.dy(i)+temp_band; 
        temp_x=temp_x'; 
%         temp_data=ave_2(temp_x); 
%         [g_a g_b g_c]=Gaussian_fit(temp_x,temp_data); 
%         roi_new.w2.dy(i)=round(g_b); 
        roi_new.w2.dy(i)=roi.w2.dy(i);  
        roi_new.w2.ry(i)=roi.w2.ry(i); 
         
        temp_image=image_2(temp_x,:); 
        temp_data=mean(temp_image); 
        temp_x=1:length(temp_data); 
        [g_a g_b g_c]=Gaussian_fit(temp_x,temp_data); 
        roi_new.w2.dx(i)=round(g_b)+xcenter2-rx2_sep-1; 
        roi_new.w2.rx(i)=roi.w2.rx(i); 
    end; 
     
    if ~roi_new.w3.sp(i) 
        roi_new.w3.dy(i)=roi.w3.dy(i); 
        roi_new.w3.ry(i)=roi.w3.ry(i); 
        roi_new.w3.dx(i)=roi.w3.dx(i); 
        roi_new.w3.rx(i)=roi.w3.rx(i); 
    else 
        temp_band=25; 
        temp_x=roi.w3.dy(i)-temp_band:roi.w3.dy(i)+temp_band; 
        temp_x=temp_x'; 
%         temp_data=ave_2(temp_x); 
%         [g_a g_b g_c]=Gaussian_fit(temp_x,temp_data); 
%         roi_new.w2.dy(i)=round(g_b); 
        roi_new.w3.dy(i)=roi.w3.dy(i);  
        roi_new.w3.ry(i)=roi.w3.ry(i); 
         
        temp_image=image_3(temp_x,:); 
        temp_data=mean(temp_image); 
        temp_x=1:length(temp_data); 
        [g_a g_b g_c]=Gaussian_fit(temp_x,temp_data); 
        roi_new.w3.dx(i)=round(g_b)+xcenter3-rx3_sep-1; 
        roi_new.w3.rx(i)=roi.w3.rx(i); 
    end; 
end; 






    if roi_new.w1.sp(i) 
        dx_offset=dx_offset+roi_new.w1.dx(i)-roi.w1.dx(i); 
        offset_count=offset_count+1; 
    end; 
end; 
if offset_count>=1 
    dx_offset=round(dx_offset/offset_count); 
    for i=1:n 
        if ~roi_new.w1.sp(i) 
            roi_new.w1.dx(i)=roi_new.w1.dx(i)+dx_offset; 
        end; 





    if roi_new.w2.sp(i) 
        dx_offset=dx_offset+roi_new.w2.dx(i)-roi.w2.dx(i); 
        offset_count=offset_count+1; 
    end; 
end; 
if offset_count>=1 
    dx_offset=round(dx_offset/offset_count); 
    for i=1:n 
        if ~roi_new.w2.sp(i) 
            roi_new.w2.dx(i)=roi_new.w2.dx(i)+dx_offset; 
        end; 





    if roi_new.w3.sp(i) 
        dx_offset=dx_offset+roi_new.w3.dx(i)-roi.w3.dx(i); 
        offset_count=offset_count+1; 
    end; 
end; 
if offset_count>=1 
    dx_offset=round(dx_offset/offset_count); 
    for i=1:n 
        if ~roi_new.w3.sp(i) 
            roi_new.w3.dx(i)=roi_new.w3.dx(i)+dx_offset; 
        end; 





% roi_new.w1.theta=zeros(1,n); roi_new.w2.theta=zeros(1,n); 
clear dx_offset image_1 image_2 offset_count rx1_sep rx2_sep rx_limit ry_limit s 
signal_power1 signal_power2; 
clear pixel temp_band xcenter1 xcenter2; 
  
data1=zeros(1,n); data2=zeros(1,n); data3=zeros(1,n); 
for i=1:n 
    
data1(i)=sum_ellipse(meas,roi_new.w1.dx(i),roi_new.w1.dy(i),roi_new.w1.rx(i),roi_new
.w1.ry(i),1); 
    
data2(i)=sum_ellipse(meas,roi_new.w2.dx(i),roi_new.w2.dy(i),roi_new.w2.rx(i),roi_new
.w2.ry(i),1); 











    b_fn=strcat(fn_b,'_',num2str(j),'.txt'); 
    b1_1=load(b_fn); 
    hb_t=hb_t+b1_1(:,2:513); 
    clear b1_1 b_fn; 
end; 
hb=hb_t/7; %Average of the 7 images; 












temp_i_sort=sort([temp_i temp_i2 temp_i3]); %Three peak value of the three 
wavelength; 
sp=[round((temp_i_sort(1)+temp_i_sort(2))/2); 
round((temp_i_sort(2)+temp_i_sort(3))/2)]; %Separate point of three bands; 
 












roi.w1=roi_1; % 705nm; 
roi.w2=roi_2; % 785nm; 
roi.w3=roi_3; % 808nm; 
 






% hb is the given imaging array; n is the detector number; 
% Modified for different rx and ry; 
  
%% Find detector center in y dimension first; 
bd=30; %half of bandwidth of detecter to seperate; 




    dm(i)=max(d_mean); 
    d_center(i)=find(d_mean==max(d_mean)); 
    if (d_center(i)-bd)<1 
        d_min=1; 
    else d_min=d_center(i)-bd; 
    end; 
    if (d_center(i)+bd)>length(d_mean) 
        d_max=length(d_mean); 
    else d_max=d_center(i)+bd; 
    end; 
    d_mean(d_min:d_max)=0; 





roi.dy=zeros(1,dn); % center of detector; 
roi.ry=zeros(1,dn); % half of FWHM of Gaussian pulse; 
G_b=20; 
for i=1:dn 
    x=(d_center1(i)-G_b):(d_center1(i)+G_b); 
    x=x'; 
    y=d_mean(x); 
    [g_a g_b g_c]=Gaussian_fit(x,y); 
    roi.dy(i)=round(g_b); 
    roi.ry(i)=round(sqrt(g_c*log(2))); 
    clear x y; 
end; 
clear dm bd d_center d_center1 dm g_a g_b g_c i; 
  





    d1(i)=round((roi.dy(i)+roi.dy(i+1))/2); 
end; 
  
%% Find detector center in x dimension; 
roi.dx=zeros(1,dn); roi.rx=zeros(1,dn); 
x_b=30; %half bandwidth of source seperation; 
for i=1:dn 
    if i==1 
        dx_begin=1; dx_end=d1(i); 
    elseif i==dn 
        dx_begin=d1(i-1); dx_end=512; 
    else dx_begin=d1(i-1); dx_end=d1(i); 
    end; 
    dx_temp=hb(dx_begin:dx_end,:); 
    dx_mean=mean(dx_temp);%mean value along the source; 
    roi.dx(i)=find(dx_mean==max(dx_mean)); 
    if (roi.dx(i)-x_b)<1 
        x_min=1; 
    else x_min=roi.dx(i)-x_b; 
    end; 
    if (roi.dx(i)+x_b)>length(dx_mean) 
        x_max=length(dx_mean); 
    else x_max=roi.dx(i)+x_b; 
    end; 
    x=x_min:x_max; 
    y=dx_mean(x); 
    clear x_min x_max; 
    [g_a g_b g_c]=Gaussian_fit(x,y); 
    roi.dx(i)=round(g_b); 
    roi.rx(i)=round(sqrt(g_c*log(2))); 
%     plot(s_mean); hold on; 
%     plot(x,g_a*exp(-(x-g_b).^2/g_c)); 












% Calculate the source-detector distance (7 by 7); 
cal=zeros(49,1); 
mp=2; a=20; b=10; 
dist=zeros(49,1); 
for i=1:7 
    for j=1:7 
        dist((i-1)*7+j)=sqrt(a^2+(i-j)^2*b^2); 







[p q]=polyfit(dist,lnr2I,1); clear q; 
y=p(1)*x+p(2); 
plot(x,y); hold on; 
plot(dist,lnr2I,'r+'); 
legend('linear fit','background data'); 
title(strcat('k=',num2str(-p(1)))); 
xlabel('Distance between source and detector (mm)'); 
ylabel('Ln(r^2I)'); 
for i=1:49 
    cal(i)=exp(p(1)*dist(i)+p(2))/dist(i)^2/data(i); 
end; 
 





%% Calibrate the measurement if we can measure a homo-background first; 
% From imaging top to bottom is detector 1 2 3 4 5 6 7; detector 1 is on 
% the top of the probe, detector 7 is closest to the handle. 
% The sequence of the switch is Source 4 5 6 7 1 2 3 according to the 
% position 1 2 3 4 5 6 7 (start - end); 
function Cal_switch_nobak(mesh, meas, f, calfile) 
% homodata is (49,1), averaged background measurement; 
% mesh is the slope fitted mesh; 
% meas is (49,1) measurement with the target; 




mp=2; a=20; b=10; 
dist=zeros(49,1); 
for i=1:7 
    for j=1:7 
        dist((i-1)*7+j)=sqrt(a^2+(i-j)^2*b^2); 
    end; 
end; 
lnr2I=log(dist.^mp.*data_am); 




    max_temp(i)=(exp(p(1)*dist(i)+p(2)))/dist(i)^2; 









plot(data_am); hold on; 
plot(data_fd.amplitude,'r-'); 










Plot the total Hb image (Codes for two wavelength) 
% Calculate the HbO and Hb 




mesh_1 = read_solution('mesh_f_mesh',out_fn_1); %785nm 
close; 
rasterize_mua(mesh_1,'y',35); 
% % % %  


































Plot the total Hb image (Codes for two wavelength) 
 







mesh_1 = read_solution('mesh_f_mesh',out_fn_1); %705nm 
close; 
rasterize_mua(mesh_1,'y',35); 
% % % %  
























extc_3=[e_1_hbo e_1_hb; e_2_hbo e_2_hb; e_3_hbo e_3_hb]; 
  



























A.4 Current in-vivo canine imaging procedure: 
The entire procedure of in-vivo canine prostate imaging is described in Fig. 83. 
 
Figure 83 in-vivo canine prostate imaging procedure 
 
A.4.1. System warm up 
This step includes the warm up of CCD, LD driver and TEC module which may take 20 
~ 30 minutes to ensure a stable system response. 
The motor stage also needs to be initialized after power on as Fig. 84. 
 
Figure 84 Labview program to initialize the motor stage 
 
The unit and command values are both set to ―1‖ then the data value is neglected. 
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Some initial parameters of Winspec are set as Fig. 85: 
 
Figure 85 Winspec setting 
 
In the ―Main‖ tag, the number of Images is set to ―7‖. In the ―Timing‖ tag, ―Timing 
Mode‖ is set to ―External Sync‖ with ―Continuous Cleans; the ―Edge Trigger‖ uses 
negative trigger edge. 
A.4.2. When dog is anesthetized, keep the probe at one position: 
A.4.2.2.1 Take the ultrasound images first by NI software: Measurement & 
Automation Explorer: 
Select NI-IMAQ devices----imag0: NI PCI-1405----Channel 0: rs170 




Figure 86 NI measurement and Automation Explorer 
 
A.4.2.2.2 Start the CCD acquisition by Winspec, then trigger the motor stage by 
Labview program shown in Fig. 87. Change the default folder to if the position data 
file is different. Then click the ―Run‖ button and the program will first need to select 




Figure 87 Labview program for CCD data acquisition 
 
A.4.2.2.3 The measured data by Winspec is in the format of *.spe file. In order to use 
the Matlab based reconstruction algorithm to calculate, the file has to be converted to 
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